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In excitable tissues, voltage-gated calcium channel activity is critical in the linkage of 
electrical stimuli to physiological responses, and so modulation of calcium channels therefore has 
significant implications. The exact mechanisms of calcium channel modulation and membrane 
expression, however, remain elusive. Previous work suggests that the calcium channel β subunit 
(Cavβ) modulates the expression and biophysical properties of the pore-forming α1 subunit. Previous 
research has shown that the core domains of Cavβ subunits are highly conserved, although alternative 
splicing in the highly variable N-terminus and HOOK regions is commonly observed in invertebrates, 
teleost fish and mammals. Splicing in these regions can produce unique isoforms that differentially 
modulate the membrane trafficking and gating properties of high voltage-activated calcium channels. 
With this in mind, two novel isoforms of an invertebrate Cavβ subunit have been identified and 
cloned from the pond snail Lymnaea stagnalis, which contain a novel N-terminus not previously 
identified. In addition, one of these novel isoforms excludes an optional, short exon in the HOOK 
region of LCavβ. Intron sequencing and amino acid alignments of the variable N-terminal and HOOK 
regions with mammalian and fish homologs have revealed that the genomic structure of Cavβ 
subuinits is conserved, despite the divergence in sequence and function between genes and splice 
isoforms. It was determined that the previously characterized LCavβ isoform, as well as the two new 
isoforms, can act to fine-tune calcium channel activity by modulating the membrane expression, 
voltage-dependencies of activation and inactivation and gating kinetics of invertebrate homologs of 
L-type (LCav1) and neuronal (LCav2) calcium channels. It is hoped that broadening our knowledge of 
simplified invertebrate calcium channels, like those found in Lymnaea, may advance our 
understanding the workings of our own highly elaborate and dynamic calcium channel complexes, 
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1.1 Voltage-gated Calcium Channels 
 
Voltage-gated calcium channels (VGCCs) perform critical functions in excitable membranes.  
VGCCs mediate the transduction of electrical signals (in the form of membrane potentials) 
into physiological responses, such as neurotransmitter release or muscle contraction (Jones, 
1998), which are initiated by a rise in intracellular calcium levels (Hille, 1992). Although 
diversity exists among the total population of VGCCs, they can be divided into two broad 
classes based on their functional characteristics. 
One class of VGCCs, referred to as the low voltage-activated (or LVA) channels, are 
open at resting membrane potentials (around -60 mV) and require only a weakly depolarizing 
stimulus to become activated (Carbone and Lux, 1984). The LVA VGCCs also display rapid 
inactivation (Carbone and Lux, 1984).  Channel activation and inactivation will be discussed 
further in section 1.1.3.  These LVA VGCCs (also referred to as T-type or Cav3 channels) are 
responsible for slow, repetitive pacemaker activity in the thalamus and in cardiac tissue 
(Hugenard, 1996). The functions more commonly associated with VGCCs are performed by 
a different class of VGCCs known as high voltage-activated (or HVA) channels. 
As the name suggests, HVA VGCCs need a strong depolarization to activate and their 
inactivation properties are highly variable.  Several subclasses of VGCCs fall into this group 
based on their electrophysiological characteristics. One class of VGCCs are known as the L-
type calcium channels (also referred to as Cav1.1, Cav1.2, Cav1.3 and Cav1.4), so-called 
 
 2 
because of their large conductance as compared to other VGCCs (Nowycky et al., 1985). The 
non-L-type channels include three groups: P/Q-, N- and R-type channels also referred to as 
Cav2.1, Cav2.2 and Cav2.3 respectively (Jones, 1998).  The non-L-type channels are 
responsible for synaptic transmitter release, while L-type channels can also be found outside 
of the nervous system, where they can be detected in skeletal, cardiac and smooth muscle as 
well as retinal tissue.  It is also possible to differentiate HVA channels according to their 
differing responses to various drugs that affect channel conductance and kinetics (their 
pharmacological properties) (Plummer et al., 1989; Mintz et al., 1992). Although the HVA 
class of VGCCs is functionally, molecularly and pharmacologically diverse, intriguingly they 
have striking structural homology. 
 
1.1.1 Voltage-gated Calcium Channel Structure 
 
VGCCs are multimeric complexes comprised of up to four distinct protein subunits, although 
as few as one may be sufficient for channel operation (Jones, 1998).  All VGCCs must at 
least contain the primary α1 subunit, which is endowed with all the major attributes of 
VGCCs including the ion-selective pore, selectivity filter, voltage sensors and drug binding 
sites (Catterall, 1996).  Aside from the α1 subunit, several auxiliary subunits may or may not 
be present in HVA VGCCs, including a β subunit, an α2δ subunit and a γ subunit which act to 
modulate the gating and membrane expression of VGCCs.  This section will concentrate on 
the structure of the primary α1 subunit. For a discussion of β subunit structure, please refer to 
section 1.2.1.   
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 The α1 subunit is comprised of four repeated, homologous domains (I-IV) connected 
by loops, each of which contains six transmembrane α-helical segments (referred to as S1- 
S6) as seen in figure 1.1 (Tanabe et al., 1987). Together, these four homologous domains 
form a tubular pore through the membrane through which calcium ions may pass. 
Mutagenesis experiments of homologous voltage-gated sodium and potassium channel 
domains have hypothesized that the voltage-sensing mechanism is found in the S4 helix of 
the transmembrane domains, which contains positively charged amino acid residues in every 
third position exposed to the surface of the channel or the pore (Stuhmer et al., 1989; Yang 
and Horn, 1995; Mannuzzu et al., 1996).  When this region is altered by site-directed 
mutagenesis, channel activity is abolished.  Aside from sensing changes in membrane 
potential, the α1 subunit must also contain a mechanism which is selective for the passage of 
calcium ions over other ionic species. 
 It is believed that the selectivity filter, as it is known, is contained in the extracellular, 
re-entrant loop between transmembrane segments S5 and S6 (also known as the P-loop).  
Each loop, contributed from all four domains, contain a critical glutamate residue which is 
necessary to attract and bind calcium ions (two at a time) with high affinity in the interior of 
the pore. It has been hypothesized that the rapid flow of ions through the pore is a balance of 
the opposing effects of calcium ions binding with high affinity to the glutamate residues and 
the repulsion between the two calcium ions bound in the pore (Yang et al., 1993).  Studies 
have shown that if these residues are altered using site-directed mutagenesis, then the 
preference of the channel to pass calcium ions is severely attenuated, if not abolished 




Figure 1.1: Domain structure of voltage-gated calcium channel  α1 subunit. Cylinders represent 
transmembrane α-helicies and lines represent linker peptides. The α interaction domain (AID) found in the I-II 
linker is highlighted by a red circle and the p-loops (hypothesized to form the selectivity filter) are surrounded 
by green circles, while the putative voltage sensor found in S4 is identified by (+) , which is indicative of the 











structural elements contained within the α1 subunit that allows them to function independent 
of any of the auxiliary subunits. 
 
1.1.2 Kinetics of Voltage-gated Calcium Channels 
 
As described in section 1.1.1, VGCCs function by allowing calcium into a cell upon the 
detection of a depolarizing stimulus.  The amount of calcium allowed into cells is determined 
by two factors, the extent to which calcium channels are expressed in the membrane and the 
gating kinetics of these channels. Logically, as the level of membrane expression is 
increased, so will the total amount of calcium entering the cell (this is referred to as the peak 
calcium current). The role of kinetics in modulating calcium entry is more complex. 
VGCCs exist in three functional states: activated, closed and inactivated (reviewed in 
Jones, 1998).  Upon detection of a depolarizing stimulus, VGCCs will activate by undergoing 
a change in conformation which allows calcium ions to pass through the pore and into the 
cytosol. This occurs very rapidly, on the scale of a few milliseconds after receiving a 
depolarizing stimulus. However, after a prolonged depolarization, VGCCs become 
inactivated. In their inactivated states, VGCCs transition to a “reluctant” state where they are 





 currents, the inactivation is seen as an exponential decay in the total current, 
even though the level of depolarization remains high.  Calcium channels recover from 
inactivation by hyperpolarization, which promotes the transition of channels from the 
refractory, inactivated state to the closed state, where they are in a “willing” state for re-
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opening. Several factors can influence channel kinetics, including membrane potential, 
calcium concentration, or interactions with other proteins including the VGCC β subunit 
(Cavβ). 
 
1.2 Voltage-gated Calcium Channel β Subunits 
 
The Cavβ subunit of VGCCs was first discovered in 1987 as a 54 kDa component of  
purified skeletal muscle dihydropyridine receptors (Takahashi et al., 1987).  The Cavβ1 
subunit was then cloned (Ruth et al., 1989), followed by the identification and cloning of 
three other mammalian Cavβ subunit genes (Cavβ2, Cavβ3 and Cavβ4) over the next five years 
(Hullin et al., 1992; Perez-Reyes et al., 1992; Castellano et al., 1993a,b).  In addition to the 
multiple genes encoding Cavβ subunits, a further level of complexity is added by the frequent 
occurrence of alternative splicing in Cavβ subunits (Foell et al., 2004).  All Cavβ subunits are 
expressed in the brain, but Cavβ subunits can be differentially expressed in other excitable 
tissues such as the heart, lungs and skeletal muscle (as reviewed in Arikkath and Campbell, 
2003).  Despite the variation among Cavβ subunits at the sequence level, their domain 
structure is highly conserved. 
 
1.2.1 Structure of the Voltage-gated Calcium Channel β Subunit 
 
For years after their discovery and cloning, the structure of Cavβ subunits were unknown. It 
was not until the late 1990s that homology modelling was employed to predict the five 
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domain structure. Hanlon and colleagues predicted a core structure of Cavβ1b resembling that 
of the membrane-associated guanylate kinase (MAGUK) protein family (Hanlon et al., 
1999). MAGUKs contain Src Homology 3 (SH3) and guanylate kinase (GK) domains, as 
well as PDZ domains (Montgomery et al., 2004). The predicted structure of the Cavβ1b 
subunit contains putative SH3 and GK domains, located at residues 100-165 and 220-430 
respectively, and a PDZ-like domain in the N-terminus (Hanlon et al., 1999).  The N- and C-
termini are structures with little identity to known motifs and so their structure was not 
clearly predicted, nor was the region bounded by the SH3 and GK domains (referred to as the 
HOOK region).  These predictions based on homology have recently been confirmed by 
studies of the crystal structure of the Cavβ subunit core (which corresponds to the SH3, 
HOOK and GK domains) (Chen et al., 2004). A ribbon diagram illustrating the crystal 
structure of the Cavβ subunit can be seen in figure 1.2A. 
 MAGUKs and Cavβ subunits share both structural and functional similarities.  
MAGUKs are scaffolding proteins found in synaptic active zones and act to organize and 
assemble a plethora of multimeric signalling complexes (as reviewed in Montgomery et al., 
2004) as well as cluster Shaker-type potassium channels (Kim et al., 1995). SH3 domains are 
often found in proteins that are localized to the inner surface of the plasma membrane (like 
Cavβ subunits), and are also known to assist in the assembly of signaling complexes (Hanlon 
et al., 1999). The Cavβ subunit SH3 domain consists of five β-sheets, which run antiparallel 
to each other in two groups which are arranged perpendicular to each other.  However, unlike 
in MAGUKs, the SH3 domain of the Cavβ subunit is interrupted between β-sheets four and 




Figure 1.2: Crystal structure of the voltage-gated calcium channel β subunit. (A) Cyrstal structure of 
conserved Src Homology 3 (SH3, yellow) and Guanylate Kinase (GK; Green) domains. The structures of N-
terminal and HOOK domains are incomplete due to the high degree of variability found in these domains. The 
position of AID peptide binding is also shown (orange, right hand side). From Chen, Y. (2004). Nature . 429, 
675-680. (B) Crystal structure of the N-terminal A-domain of the  Cavβ4a subunit . From Vendel, A.C. et al. 








domain folding. Typically, MAGUK-SH3 domains are involved in the binding of proline-
rich peptides (McPherson, 1999), but the crystal structure of the Cavβ subunit reveals that 
these putative binding sites are occluded in the Cavβ-SH3 domain (Chen et al., 2004). Recent 
work has shown that the SH3 domain can bind to the I-II linker and C-terminus of the 
primary α1 subunit (Dubuis et al., 2006), and that dynamic rearrangements of this domain are 
possible in order to expose the putative proline binding sites (Gonzalez-Gutierrez et al., 
2007) allowing for the possible interaction of many proteins with the SH3 portion of the Cavβ 
subunit. Further work is needed to validate the role of the SH3 domain in VGCC modulation 
and trafficking. 
The putative Cavβ-GK domain was identified by its homology to GK domains found 
in yeast proteins, as it contains a repeating β-α-β motif but lacks the ATP-binding site 
necessary for kinase activity (Hanlon et al., 1999). Interactions with other proteins, most 
notably the VGCC α1 subunit, occur via the GK domain. Studies of the crystal structure of 
the GK domain (Chen et al., 2004), as well as biochemical assays and analysis of truncated 
proteins (De Waard et al., 1994; Pragnell et al., 1994) have shown that the GK domain 
contains a β Interaction Domain (BID) which is required for binding to the primary α1 
subunit. The BID is 30 amino acids long and by mutating key residues within it, De Waard et 
al. were able to abolish the high-affinity binding of β subunit to the α1 subunit, and show that 
the functional effects of the β subunits had disappeared (De Waard et al., 1994). Similar 
studies were completed in α1 subunit to determine that a region of 18 amino acid residues in 
the linker between domains I and II, known as the α Interaction Doman or AID (see figure 
1.1), is responsible for interacting with the Cavβ subunit (Pragnell et al.,1994).   
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More recent studies have questioned the nature of the interaction between the AID of 
α1 subunits and BID of the Cavβ subunit. The crystal structure of the Cavβ subunit shows that 
the BID does not interact directly with the AID, but instead that the AID interacts with a 
small hydrophobic groove in the GK domain, opposite the SH3 domain (Chen et al., 2004). 
This leaves the majority of the surface of the Cavβ subunit free to interact with other regions 
of the α1 subunit or other proteins. It has been postulated that the role of the BID is structural, 
in that it acts as a stabilizing bridge between the SH3 and GK domains (Chen et al., 2004). 
This hypothesis is supported by other studies that have shown that truncated Cavβ subunits 
which lack the BID and most of the GK domain still have modualtory effects on VGCC 
biophysics (Harry et al., 2004; Cohen et al., 2005).  
To further investigate the nature of the AID-Cavβ interaction, other groups have 
transferred the AID region from HVA VGCCs to the I-II loop of LVA T-type channels, 
which are not known to be associated with auxiliary subunits. Interestingly, when the AID 
domain was added to the I-II loop of the T-type channel, some (but not all) of the typical 
modulatory effects of Cavβ subunits- increased peak current and hyperpolarization of the 
activation curve- were observed (Arias et al., 2005). This work builds upon the direct 
coupling hypothesis, which states that channel gating is modulated by the Cavβ subunit 
regulation of the conformational changes seen in the IS6 transmembrane segment of α1 
during activation and inactivation (Hering, 2002). In order for this to occur there must also be 
a rigid link between the end of IS6 and the AID. To test this hypothesis, deletions and 
mutations were made to the 22 amino acid region which connects IS6 to the AID in Cav2.2 
and assessing the biophysical effects. If amino acids in the IS6-AID linker thought to 
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represent β-sheets are replaced by glycine residues (to increase flexibility and disrupt β-sheet 
formation) all Cavβ subunit effects were removed (Vitko et al.,2008). It was also found that 
deletion of even a single amino acid in this region was sufficient to abolish all of the effects 
of Cavβ subunit expression, with the exception of its ability to assist in the assembly and 
membrane trafficking of the α1 subunit (Vitko et al., 2008). It was determined, using 
bimolecular fluorescence complementation (BiFC) analysis, that deletions in the IS6-AID 
linker had disrupted β-sheet formation and had shifted the orientation of the Cavβ subunit by 
180˚, leading to the conclusion that the role of the AID is to anchor the Cavβ subunit so that it 
is positioned towards other regions of α1 where lower affinity binding promotes modulation 
of channel gating (Vitko et al., 2008). Furthermore, studies investigating the specific roles of 
the individual domains have raised speculation that the SH3 domain is more active in 
promoting interaction with α1 than the crystal structure data suggests. For instance, Maltez et 
al. (2005) showed that some β subunit functions can be achieved without interaction with the 
AID, and that the SH3 domain can bind directly to the I-II linker outside of the AID region.  
Although it is clear that the SH3 and GK domains interact with α1 to modulate its biophysical 
properties, much work remains in order to fully understand the true nature of VGCC 
modulation by the Cavβ subunit core. 
As discussed, the SH3 and GK domains are highly conserved among all Cavβ 
subunits. So how are Cavβ subunits able to interact with the various classes of VGCCs in an 
isoform specific manner? The answer may lay in the hypervariable A domain, located at the 
N-terminus. The recently published solution structure of the N-terminal A domain of Cavβ4a 
(seen in figure 1.2B) shows that this domain folds independently and points away from the 
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SH3-HOOK-GK core (Vendel et al., 2006). The domain is comprised of two α-helicies 
positioned antiparallel to one another with two β-sheets and three connecting loops which 
surround a small hydrophobic core (Vendel et al., 2006).  The second α-helix is stabilized 
through an interaction with the SH3 domain which is important in ensuring that the N-
terminus is oriented away from the rest of the protein. Since it has been shown that the A 
domain does not directly interact with the α1 subunit (Maltez et al., 2005), perhaps this 
domain exerts its influence on channel function indirectly by interacting with other proteins 
that bind to and modulate α1. This notion is especially attractive as it is known that the A 
domain has a high rate of alternative splicing, and previous work has shown α1 isoform-
specific modulation by Cavβ4a splice variants of the A domain (Helton and Horne, 2002). 
Alternative splicing in the N-terminus and HOOK regions likely plays a large role in the 
specific modulation of various α1 subfamilies, especially in invertebrates like the freshwater 
pond snail Lymnaea, where only a single Cavβ subunit homolog is present (Spafford and 
Zamponi, 2003).  
 
1.2.2 Functional Effects of β Subunit Expression 
 
 
Cavβ subunits serve as critical modulators of VGCC expression and gating, and these tasks 
are achieved independently of one another (Gerster et al., 1999). It has long been known that 
the overexpression of all four mammalian Cavβ subunits in excitable cells results in increased 
density of calcium currents through both L-type and non-L type HVA VGCCs (Neuhuber et 
al., 1998; Raghib et al., 2001; Colecraft et al., 2002). This increase in current density (seen 
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as increased whole-cell peak calcium current) is due to the role of Cavβ subunits in the 
membrane trafficking of the primary α1 subunit.  
It has been shown that the I-II loop of α1 contains an endoplasmic reticulum (ER) 
retention signal which can be antagonized by the Cavβ subunit (Bichet et al., 2000).  If the 
Cavβ subunit is not co-expressed with α1, immunolabeling and deletion analysis reveals that 
the ER retention signal drastically restricts the level of α1 expressed in the membrane and α1 
remains confined to the ER (Bichet et al., 2000). Masking of the ER retention signal, 
presumably through AID-BID interaction, allows α1 to escape the ER and become inserted in 
the membrane. Despite their similar roles in the membrane trafficking of α1, the four 
mammalian Cavβ subunits (and their splice isoforms) differ in their modulation of channel 
gating and kinetics. 
  The ability of the various Cavβ subunits to uniquely alter the gating properties of α1 
is one of the primary ways in which VGCCs are regulated temporally and spatially. The 
modulation of VGCC kinetics is specific to the unique combination of α1 and Cavβ subunits 
which are expressed in a given cell (Sokolov et al., 2000), and therefore the functionality of 
VGCCs in a given cell can be fine-tuned by modifying the expression of the four Cavβ 
subunit genes. The gating properties of α1 may be altered by modulating the voltage-
dependency and/or kinetics of activation, inactivation or both. All of the mammalian Cavβ 
subunits induce a hyperpolarizing shift in the voltage-dependence on activation (He et al., 
2007), which translates functionally to the channels activating at a more negative potential 
(i.e. less depolarization above resting potential is required). When inactivation induced by 
Cavβ subunit overexpression was studied, it was noted that Cavβ1b, Cavβ3 and Cavβ4 all 
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increased the speed of inactivation, and shifted the voltage-dependence in a hyperpolarizing 
direction (He et al., 2007). This means that a greater fraction of VGCCs will begin to close at 
more negative potentials after being open for less time, resulting in a calcium current which 
will disappear more rapidly than if Cavβ subunits are not expressed. Conversely, inactivation 
was significantly slowed by the expression of Cavβ2a and the voltage dependence on 
inactivation was shifted to more depolarizing potentials (He et al., 2007), meaning VGCCs 
can remain open longer and do not significantly inactivate at lower potentials. Knowing that 
the core structure of the β subunit is remarkably conserved, how can these functional 
differences be accounted for? Many studies have implicated the hypervariable N-terminus 
and HOOK regions in the endowment of isoform-specific properties. 
As shown by Bichet and colleagues, Cavβ subunits mask an ER retention signal found 
in the I-II linker of α1 in order to facilitate membrane expression. It was later shown that the 
same effect could be achieved by the co-expression of α1 with a truncated Cavβ subunit 
comprised of only the BID-containing GK domain (He et al., 2007). Although the trafficking 
of α1 was enhanced by Cavβ-GK expression, there was only a slight modulation of the gating 
properties. Co-expression of α1 with Cavβ-GK resulted in whole-cell currents which 
inactivated rapidly, showing only a slight, insignificant deviation amongst  all four 
mammalian Cavβ subunits (He et al., 2007; Richards et al., 2007). Therefore, it was 
concluded that although the AID-GK interaction firmly anchors Cavβ to α1 to assist with 
trafficking, gene- and isoform-specific modulation must occur via lower affinity interactions 
in the more variable regions which flank the GK domain (He et al., 2007).  
 
 15 
In order to elucidate the role of the N- and C-termini, as well as the HOOK region, 
several studies of truncated Cavβ subunits were carried out. It was clear that the C-terminus, 
although relatively divergent between subfamilies was not responsible for modulating the 
changes in gating, as channels expressed with Cavβ subunits truncated at the C-terminus were 
biophysically identical to wild-type (He et al., 2007). Evidence suggests that the distal N-
terminus and the HOOK region are involved in modulating the inactivation of VGCCs. When 
α1 was co-expressed with either full-length Cavβ subunits or Cavβ subunits containing only 
the core domains (SH3-HOOK-GK) it was noted that the inactivation kinetics of each pair 
(e.g. β2: full length versus truncated) were markedly different (He et al., 2007). This suggests 
that the N-terminus is participating in the subfamily-specific regulation of α1 since both 
constructs contained the same HOOK region and C-terminus. He and colleagues (2007) 
hypothesized that the HOOK region must also be involved in channel inactivation since there 
was remarkable variation in the inactivation properties among the four Cavβ subunit cores.   
To test this theory, the HOOK regions of Cavβ1b and Cavβ2a were swapped, and it was 
noted that Cavβ1b (which usually facilitates inactivation) was inhibiting inactivation (as is 
usually the case for Cavβ2a) and vice versa (He et al., 2007). This model is further supported 
by experiments which demonstrate that if the HOOK region of Cavβ2a is deleted, rapid 
inactivation is observed (Richards et al., 2007). Other work shows that expression of the GK 
domain alone is sufficient to inhibit inactivation of α1 even among Cavβ1, Cavβ3 and Cavβ4, 
which suggests that the facilitation seen in those Cavβ subunits is controlled by regions 
outside of the GK domain (Gonzalez-Gutierrez et al., 2008). Overall, it is safe to say that 
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much remains to be learned about how the biophysical properties of the α1 subunit are 
modulated by mammalian Cavβ subunits. 
Finally, an additional level of complexity is added by the fact that modulation of 
channel function is possible through the interaction of Cavβ subunits with other proteins 
outside of the VGCC complex. These include enzymes like mitogen-activated protein kinase 
(MAPK) (Fitzgerald, 2002), and protein kinase A (PKA) (as reviewed in Arikkath and 
Campbell, 2003) and regulatory proteins, including members of the G-protein family such as 
Gem (Beguin et al., 2001). The interaction of other proteins with Cavβ subunits can produce 
a variety of effects on membrane trafficking and gating of the primary α1 subunit. 
 
1.3 Lymnaea stagnalis as a Model Organism in Neuroscience 
 
 
The fact that mammals express four genes for Cavβ subunits can quickly confound our ability 
to understand the fundamental concepts involved in their modulation of VGCCs. For this 
reason, molluscs such as the freshwater pond snail Lymnaea stagnalis, are ideal as they 
contain only a single Cavβ subunit homolog (LCavβ) and two HVA α1 homologs (known as 
LCav1 and LCav2) for the seven mammalian α1 genes (Spafford et al., 2006; Spafford et al., 
2003). LCav1and LCav2 are homologs to the L-type and non-L-type HVA channels, 
respectively. As reported by Spafford et al. (2004), the L Cavβ subunit has little effect on the 
membrane expression and overall kinetics of LCav2 channels. The only significant finding 
was that the co-expression of LCavβ with LCav2 caused a slowing of inactivation decay 
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(Spafford et al., 2004). Since it is a common feature of Cavβ subunits to facilitate membrane 
trafficking of α1, but invertebrates do not contain multiple Cavβ subunit genes, it is very 
likely that unidentified alternative splice isoforms exist in Lymnaea in order to facilitate 
channel type-specific membrane trafficking. 
It is the goal of this project to identify novel splice isoforms of LCavβ in the N-
terminal region, which is thought to be highly variable. These isoforms will then be cloned 
and characterized electrophysiologically (with both LCav1 and LCav2), and the patterns of 




Materials & Methods 
 
2.1 Screening of cDNA Library for Novel LCavβ Subunit Variants 
 
In order to determine if alternative splice isoforms of the LCavβ N-terminus were present, 
cDNA libraries were screened by nested polymerase chain reaction (PCR) using degenerate 
primers.  Amplified products were then purified and sequenced before being cloned into a 
full-length LCavβ subunit in the mammalian expression vector pMT-2SX(R). These steps are 
described in further detail below. 
 
2.1.1 Degenerate Primer Design for Library Screening 
 
In order to determine if alternative splicing is present in the N-terminus of LCavβ, a cDNA 
library constructed from Lymnaea cerebral ganglia was screened using a degenerate primer 
set and vector specific primers. These nested primers are referred to as LCavβ 1exon1b-outer 
and Lymnaea-beta-degen and their sequences are displayed in table 2.1. The relative 
locations of all primer sites used in cloning and sequencing are illustrated in figure 2.1. The 
vector used in the construction of the cDNA library, λZAP, contained universal primer sites 
for the following primers (whose sequences are also displayed in table 2.1): T77, T33, EV2 
and EV3.  Since the orientation of the cDNA insert in the library was unknown, each fraction 
was screened in either direction using either the EV3/T33 or EV2/T77 primer sets. Therefore,  
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Table 2.1: Primer Sequences used in library screening and cloning (restriction sites are highlighted) 




















for the primary PCR the primers used were “LCavβ1exon1b-outer” with either EV2 or EV3, 
while “Lymnaea- LCavβ -degen” and either T77 or T33 were used for the secondary PCR. 
 
2.1.2 Polymerase Chain Reaction 
 
Polymerase chain reactions (PCRs) were preformed in a volume of 25μL.  In preparation for 
the primary PCR, each reaction component was diluted to the following concentrations in 
sterile Milli-Q water: 1X Taq Buffer with (NH4)2SO4 (Fermentas, #B33), 2.5mM MgCl2, 
0.2mM of each deoxyribonucleotide (dATP, dGTP, dCTP, and dTTP; Fermentas #R0192) 
and 1μM each of the forward and reverse primers (described in section 1.1.1).  Next, 0.2μL 
of cDNA template was added, as was 0.2 units of Taq DNA polymerase (Fermentas, 





Figure 2.1: Location of primer sites utilized in the cloning and sequencing of LCavBB. Primer sites and 
directions are indicated by black arrows. Black regions represent 5’ UTR sequence, while blue represents the N-











was prepared for each round of PCR, for a total of 25 reactions. Each reaction was then 
placed in an Eppendorf AG Mastercycler ep thermocycler (Eppendorf, # 950000015) and 
heated to 95°C for two minutes to denature the DNA. Next, the reactions underwent 30 
cycles of heating to 94°C for one minute, 56°C for 45 seconds then 72°C for four minutes. A 
final elongation of ten minutes at 72°C was added after the cycling was complete. 
 For the secondary PCR, the same reaction conditions and cycling parameters were 
used as described above except that 0.2μL of the primary PCR was added in place of 0.2μL 
of cDNA library for template.  Upon completion of the secondary PCR, results were 
visualized on an agarose gel. 
 
2.1.3 Agarose Gel Electrophoresis 
 
To visualize PCR products, a 1% agarose gel was made by dissolving 0.7g of agarose in 
70mL of boiling Tris-Acetic acid-Ethelenediaminetetraacetic acid (EDTA) buffer (TAE 
buffer). Before casting, the gel was allowed to cool, and three to five drops of 0.1% ethidium 
bromide were added.  The gel was then cast and a comb was inserted into the molten agarose. 
After solidification of the gel, 5μL of 6X loading dye was mixed with the secondary 
PCR product and loaded into the agarose gel, as was 6μL of GeneRuler 1kb DNA Ladder 
Plus (Fermentas, #SM1333) to mark the size of any amplified products. Gels were then run at 
120V for approximately 30 minutes to allow for separation of the ladder. The gel was 
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visualized under ultraviolet (UV) light on an AlphaImager HP gel documentation system 
(Alpha Innotech, # 92-13823-00) and a digital photograph was taken. 
 
2.1.4 PCR Product Purification 
 
Any PCR products visualized on the gel were excised and purified using the QIAquick PCR 
Purification Kit (QIAGEN, #28104). The protocol was carried out according to the 
manufacturer’s instructions with the following deviations: the DNA-buffer mixture was run 
through the column twice at 4500 x g, the water used for elution was pre-heated to 65°C, and 
the eluted fraction was run through the column a second time. To ensure samples were not 
lost during purification, 5μL of each sample were run on an agarose gel as described in 
section 2.1.3. 
 
2.1.5 Sequencing of PCR Products 
 
The concentration of purified PCR products was adjusted to approximately 20ng/μL using a 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies). The samples were then 
sent for DNA sequencing using the dye-termination method at the University of Waterloo’s 




2.2 Cloning of the Novel LCavβ Subunit N-terminus 
 
In order to express the novel LCavβ splice isoforms in mammalian cells, the genes were 
cloned into a suitable mammalian expression vector.  To achieve this task, new, specific 
primers containing restriction sites were designed and used to amplify the N-terminus of 
LCavβ from freshly prepared cDNA. These products were then cut with restriction enzymes 
and ligated into a mammalian expression vector containing the downstream portion of 
LCavβ, known as LCavβ-pMT2SX(R). 
 
2.2.1 Primer Design for Cloning the Novel LCavβ N-terminus 
 
In order to clone the novel LCavβ N-terminus, known as LCavβB, into the full-length LCavβ 
subunit, new nested primer sets containing restriction sites were ordered from Sigma-
Aldrich.  To target the N-terminal start site the primers LCavβMf (outer) and 
LCavβ1bNotATG (inner) were created. The inner primer, LCavβ1bNotATG contains a NotI 
restriction site (5’- GCGGCCGC -3’) four base pairs upstream of the start of the open 
reading frame (ORF) to facilitate cloning. The reverse primers, LCavβBlpIbb (outer) and 
LCavβBlpIb (inner), were designed to target a region one kilobase (kb) downstream of the 
start of the ORF and were chosen because they contain a BlpI restriction site (5’- 




2.2.2 Reverse Transcription and Polymerase Chain Reaction for Full-length 
Clone 
 
Total RNA was extracted from Lymnaea stagnalis tissue (frozen in liquid nitrogen and 
ground to a fine powder) using a modified TRIZOL-reagent (Applied Biosystems, 
#AM9738) protocol carried out by Adriano Senatore.  To carry out the reverse transcription 
and create cDNA, 2μL of BlpIbb primer (1μM) were combined with 1μL of dNTPs (10mM) 
and 5.5μL of milli-Q water, which was then heated to 65°C for five minutes before adding 
4.5μL of total RNA extract.  This mixture was incubated at 65°C for an additional five 
minutes, followed by a five minute incubation on wet ice to denature any secondary structure 
present in the RNA.  Next, the sample tube was briefly centrifuged to collect the sample at 
the bottom of the tube before adding 4μL of 5X First Strand Buffer (Invitrogen, # 18080-
093), 1μL of 100mM Dithiothreitol (DTT), 1μL of RNase Inhibitor, and 200 units of 
SuperScript III Reverse Transcriptase (Invitrogen, # 18080-093). The total reaction volume 
of 20μL was then incubated at 54°C for 80 minutes, followed by 15 minute incubation at 
70°C. The cDNA was then held at 4°C or frozen at -20°C until used in PCR. 
 PCRs were performed as described in section 2.1.2, except that 1μL of cDNA was 
added to the reaction instead of 0.2μL. The primers sets (forward/reverse) employed for the 
primary and secondary PCRs were LCavβMf/ LCavβBlpIbb and LCavβ1bNotATG/ 
LCavβBlpIb, respectively. The PCRs (both primary and secondary) were then visualized by 




2.2.3 Phenol-Chloroform Extraction and Ethanol Precipitation 
 
Next PCR products were purified by phenol-chloroform extraction. Remaining PCR products 
were diluted to a final volume of 100μL with milli-Q water and transferred to a 1.5mL tube 
before one volume (100μL) of phenol-chloroform (1:1 volume ratio) were  added. The 
mixture was vortexed at maximum speed before being centrifuged at 21,130 x g for five 
minutes. After centrifugation, the aqueous phase was removed and placed in a new 1.5mL 
tube. This process was repeated until no white precipitate was visible between the aqueous 
and organic phases. To remove traces of phenol from the aqueous phase, one volume 
(100μL) of pure chloroform as added. This mixture was vortexed and centrifuged as before 
and the aqueous phase was then placed in a new tube. 
To precipitate the DNA from the aqueous phase, an ethanol precipitation was carried 
out by adding one tenth volume (10μL) of 3M sodium acetate (pH5.2) and vortexing. Next, 
two volumes (220μL) of 100% ethanol were added. The tube was mixed by inversion and 
placed on ice for one hour before being centrifuged at 16,100 x g at 4°C for ten minutes to 
pellet precipitated DNA. The pellet was washed with 70% ethanol and allowed to air-dry.  
The air-dried pellet was then resuspended in 47.5μL of milli-Q water that was warmed to 





2.2.4 Restriction Digestion and Gel Purification 
 
To prepare the N-terminal LCavβB PCR fragment and full-length LCavβ-pMT2SX(R) for 
ligation, both were double-digested with the restriction enzymes NotI (New England Biolabs, 
# R0189S) and BlpI (New England Biolabs, # R0585S) in separate 200μL tubes.  Each digest 
contained the appropriate volume of 10X NEBuffer2 (New England Biolabs, # B7002S) 
supplemented with Bovine Serum Albumin (BSA; New England Biolabs, # B9001S) to a 
final concentration of 0.1mg/mL, 4μL of NotI and 2μL of BlpI. The entire purified PCR 
product was added to one tube for a final volume of 60μL. To the other tube 10μg of LCavβ-
pMT2SX(R) was added and Milli-Q water was used to reach a final volume of 60μL. Both 
tubes were incubated at 37°C overnight to ensure complete digestion.  
The restriction digest reactions were then visualized on a 1% agarose gel as described 
in section 2.1.3. In the gel lane containing the N-terminal PCR product digested with NotI 
and BlpI, the single 1014bp band was excised. In the lane containing LCavβ-pMT2SX(R), the 
5.4kb band was excised, while the 1kb band was discarded. The excised bands were purified 
using the Illustra GFX PCR DNA and Gel Band Purification kit (General l Electric 
Healthcare, # 28-9034-70) according to the manufacturer’s instructions with the same 




Following digestion and purification, the PCR fragment (hereafter referred to as the “insert”) 
and the 5.4kb fragment purified from the digest of LCavβ-pMT2SX(R) (hereafter referred to 
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as the “vector”) were ligated to form the novel construct LCavβB-pMT2SX(R) (the previously 
cloned LCavβ subunit will hereafter be referred to as LCavβ A). Five ligation reactions were 
preformed in total, each of which contained a different ratio of insert to vector. Each ligation 
reaction contained 1μL of T4 ligase enzyme (New England Biolabs, #M0202), 1.5μL of 10X 
T4 ligase buffer (new England Biolabs, #B0202), and 0.5μL of vector. To each of the five 
tubes 0, 1, 3, 5 or 10μL of insert were added and the final volume was adjusted to 15μL with 
milli-Q water.  The ligation reaction containing no insert served as a negative control for the 
presence of background colonies. These reactions were incubated overnight at 16°C. 
 
2.2.6 Heat Shock Transformation into DH5α Cells 
 
The ligations were then transformed into bacteria, where the plasmids could be grown-up, 
purified and screened for the presence of LCavβB-pMT2SX(R). For transformation, the 
Escherchia coli strain DH5α was chosen because it is capable of transformation by heat 
shock and grows rapidly. Aliquots of frozen DH5α were thawed on wet ice.  In separate pre-
chilled 200μL tubes, 100μL of thawed cells were mixed thoroughly with 5μL of each of the 
ligation reactions, including the negative control, and chilled on wet ice for 20 minutes. The 
tubes were then heated to 42°C for 90 seconds before rapid chilling on wet ice for an 
additional two minutes. 
 The contents of each tube were then transferred to 1mL of Luria Bertani (LB) broth in 
a 1.5mL tube and incubated at 37°C for 45 minutes while shaking at 450 rpm.  Upon 
completion of the incubation, each tube was centrifuged at 4500 x g to pellet the bacterial 
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cells. The supernatant was discarded and the cells were resuspended in 50μL of fresh LB 
broth before being plated on LB agar plates containing 0.1mg/mL ampicillin (EMD 
Chemicals, #171254). The plates were then inverted and incubated at 37°C overnight. The 
following morning, plates were inspected for the presence of colonies and two colonies from 
each plate (including the negative control plate) were used to inoculate 5mL of LB broth 
containing 0.1mg/mL ampicillin. These cultures were incubated at 37°C for two days while 
shaking at 450rpm to allow the bacteria to multiply and produce large quantities of plasmid. 
 
2.2.7 Plasmid Isolation by Alkaline Lysis (Adapted from Birnboim and Doly, 1979) 
 
In order to isolate the plasmids contained in each bacterial culture sample, a modified 
alkaline lysis method was employed. The following method describes the isolation procedure 
for one sample.  The entire procedure is carried out in 1.5mL plastic tubes. To the tube, 
1.5mL of bacterial culture was decanted and centrifuged at 4500 x g for two minutes to pellet 
the bacteria. The supernatant was then discarded and if there was not a large pellet (roughly 
filling the bottom 5mm of the tube), then this process was repeated. The pellet was then 
resuspended in 150μL of Glucose Tris-EDTA (TE) buffer (50mM glucose, 25mM Tris-HCl, 
10mM EDTA, pH8.0). To lyse the cells, 300mL of freshly prepared lysis buffer [1%(w/v) 
sodium dodecyl sulfate (SDS), 0.2N NaOH) was added and the tube was gently mixed by 
inversion and placed on ice for up to five minutes before the addition of 225μL of ice-cold 
potassium acetate solution [3M potassium acetate, 11.45% (w/v) glacial acetic acid] to 
precipitate the cellular debris and genomic DNA. The mixture was then vortexed for 
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approximately five seconds or until a cottage cheese-like precipitate was visible. The tube 
was then centrifuged at maximum speed at 4°C for five to ten minutes (until the cellular 
debris and genomic DNA had formed a tight pellet against the wall of the tube). 
 The supernatant was transferred to a fresh tube and 405μL of 2-propanol was added. 
The tube was mixed by inversion before incubation at -20°C for at least 30 minutes to allow 
plasmid DNA to precipitate. The tube was then spun in a centrifuge for ten minutes at 
maximum speed at 4°C to pellet the precipitate. The supernatant was discarded and the pellet 
was allowed to air dry prior to resuspension in 100μL of TE buffer (10mM Tris-HCl, 1mM 
EDTA, pH 8.0). RNase A (Sigma, #R4875) was then added to a final concentration of 
20μg/mL, and the sample was incubated at 37°C for 15 minutes. To complete the plasmid 
isolation, phenol-chloroform extraction and ethanol precipitation were preformed as 
described in section 2.2.3. The plasmid pellet was resuspended in 50μL of warm Milli-Q 
water. This procedure was repeated for all ten samples. 
 
2.2.8 Screening Clones by Restriction Digestion 
 
In order to determine if isolated plasmids contained the LCavβB insert, sequential digestions 
with the restriction enzymes SalI (New England Biolabs, #R0138) and BlpI were preformed. 
These enzymes were chosen because BlpI is found inside of LCavβB, whereas SalI is found in 
the vector, pMT2SX(R), just upstream of the NotI site used in cloning. Approximately 2μg 
of each plasmid was combined with 1μL NEBuffer1 supplemented with BSA to a final 
concentration of 0.1mg/mL, 1μL of SalI and diluted to a final volume of 10μL with Milli-Q 
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water. These digests were incubated at 37°C for four hours then purified by phenol-
chloroform extraction and ethanol precipitation as in section 2.2.3. The DNA pellets were 
resuspended in 17μL of warm Milli-Q water. 
 To perform a second digest with BlpI, 2μL of NEBuffer4 and 1μL of BlpI were added 
to the resuspended DNA. The digest was then incubated another four hours before the results 
were visualized on a 1% agarose gel as in section 2.1.3. 
 
2.2.9 Sequencing of LCavβB-pMT2SX(R) 
 
Isolated plasmids which gave positive results in the restriction fragment length 
polymorphism (RFLP) screening were sent for sequencing at Robarts Research Institute at 
the University of Western Ontario. Plasmids were sequenced in the reverse direction with the 
primer LCavβBlpIb. 
 
2.3 Creation of In Situ Probes for Southern Blotting 
 
It was necessary to clone out small, unique sequences of the untranslated region (UTR) 
upstream from each LCavβ subunit isoform into pBluescriptII SK(+),  a shuttle vector, so that 
probes could be created to identify each isoform uniquely.  Similar to the methods described 
in section 2.2, the desired regions were amplified by PCR, then digested with restriction 




2.3.1 Primer Design 
 
Unique sequences of each LCavβ subunit isoform were chosen based on their small size and 
GC content (approximately 50%). Primers were designed to amplify these regions and 
incorporate 5’ KpnI and 3’ SacI restriction sites into the fragment to facilitate cloning into 
pBluescriptII. These restriction sites were chosen since they are the most distal in the 
multiple cloning site which enables one to amplify the cloned regions using primer sites 
found in the vector with minimal amplification of vector sequence. The primers 
(forward/reverse) for LCavβA and LCavβB are known as LCavβ-aKpnf/ LCavβ-aSacb and 
LCavβ-bKpnf/ LCavβ-bSacb, respectively. The sequences of the primers can be found in table 
2.1.  
 
2.3.2 Polymerase Chain Reaction 
 
Unique N-terminal regions were then amplified by PCR from specific DNA library fractions. 
For LCavβA , parasitized Lymnaea library fraction #11 was used as the template, whereas for 
LCavβB, Lymnaea cerebral ganglion cDNA library fraction C was used. The reactions were 
carried out as described in section 2.1.2, with the following deviations: the total reaction 
volume was increased to 50μL, the concentration of MgCl2 was decreased to 1.5mM, the Taq 
was replaced by 0.25μL of a Taq/Vent polymerase (20:1) mixture (Vent DNA polymerase, 
New England Biolabs, #M0254), and the extension time during the 72°C cycle was 
decreased to one minute. Also, each reaction was performed in duplicate. The results were 
then visualized by loading 5μL of each reaction on a 1% agarose gel as in section 2.1.3. 
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2.3.3 Restriction Digestion with KpnI and SacI 
 
Prior to restriction digestion, the duplicate PCR reactions were combined and purified by 
phenol-chloroform extraction and ethanol precipitation as in section 2.2.3. The DNA was 
resuspended in 47.4μL of Milli-Q water. To the DNA, 6μL of 10X NEBuffer1 was added, as 
was 3μL each of SacI (New England Biolabs, #R0156) and KpnI (New England Biolabs, 
#R0146). This mixture was supplemented with 0.6μL of 10mg/mL BSA. To facilitate 
cloning, 10μg of pBluescriptII SK(+) was also cut with SacI and KpnI in a similar fashion, 
except that water was added to bring the final volume to 60μL. All digestions were incubated 
overnight at 37°C. The next day, the pBluescript vector was dephosphorylated by 
supplementing the digest with 4μL of 10X Antarctic Phosphatase buffer (New England 
Biolabs, #B0289), 5μL of milli-Q water and 1μL of Antarctic Phosphatase (New England 
Biolabs, #M0289). This reaction was incubated for 30 minutes at 37°C. Dephosphorylation 
helps to reduce the occurrence of vector re-circularization. 
 Results were visualized on a 1% agarose gel as in section 2.1.3. The bands 
representing the unique N-terminal fragments and the large band of the pBluescript vector 
were excised from the gel and purified as in section 2.2.4. Concentrations of the purified 








Ligations were performed by diluting 10X T4 ligase buffer to a final concentration of 1X in 
the presence of 53.1ng of pBluescript vector and 1μL of T4 ligase. The LCavβ subunit 
sequences were added in various amounts to give an insert to vector ratio (I:V) of 0 (negative 
control), 1, 3, 5 and 10, which was calculated using the following formula: 
ng(insert) = [I:V][ng(vector)x kb(insert)]/[kb(vector)] 
where ng represents mass and kb represents size in kilobases. These ligation reactions were 
incubated at room temperature for four hours. Ligation reactions were then transformed into 
DH5α cells and the plasmids were isolated as in sections 2.2.6 and 2.2.7, respectively. 
 
2.3.5 Screening Plasmids by Restriction Fragment Length Polymorphism 
 
Plasmids were screened for the presence of the unique N-terminal inserts by restriction 
fragment length polymorphism (RFLP). One microgram of each plasmid was cut with 1μL 
each of KpnI and SacI in the 2μL of NEBuffer2 supplemented with 0.1mg/mL BSA. Water 
was added to a final volume of 20μL, and digests were incubated at 37°C overnight. Results 









Isolated plasmids which gave positive results in the RFLP screening were sent for 
sequencing at the Molecular Core Facility at the University of Waterloo. Plasmids were 
sequenced bi-directionally using the primers T7 and T3 found in pBluescriptII SK(+). 
 
2.3.7 Synthesis of Digoxigenin-labeled DNA Probes by Polymerase Chain 
Reaction 
 
In order to identify the localization of LCavβ subunits in digested genomic DNA, DNA 
probes will be labeled with digoxigenin (DIG). The DIG-labeled nucleotides will be 
incorporated using PCR, and will be compared to a control PCR without DIG-labeled 
nucleotides. The DIG-labeling should cause a slight shift in band position on an agarose gel, 
as the DIG-labeled nucleotides are of a higher molecular weight. Both reactions contained 
the following: 1.125mM MgCl2, 0.5μM each of the forward and reverse primers (as in 
section 2.3.1) and 0.25μL of Taq DNA polymerase, and 0.25ng of plasmid (either LCavβA or 
LCavβB fragments in pBluescript) as template. Also, for both LCavβA and LCavβB, these 
reactions were carried out in duplicate, except that one contained 0.1mM dNTPs, while the 
other contained 0.1mM each of dATP, dGTP and dCTP, 85μM dTTP and 15μM DIG-11-
dUTP (alkali-liable; Roche, # 11573152910).    
Each reaction was then placed in an Eppendorf AG Mastercycler ep thermocycler and 
cycled as in section 2.3.2. The entire PCR reaction was then loaded on an agarose gel as and 
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visualized as in section 2.1.3. The bands representing DIG-labeled fragments were excised 
and purified as in section 2.2.4. The purified, double-stranded, DIG-labeled DNA probes 
were eluted in 50μL of water and stored at -20°C. 
 
2.4 Genomic DNA Extraction from Lymnaea stagnalis 
 
In order to examine the genomic structure of the LCavβ gene, genomic DNA must be freshly 
extracted from Lymnaea tissue in a procedure modified from van Moorsel et al. (2000).  To 
prepare for extraction, about five large snails were anesthetized in tank water containing 10% 
Lysterine mouthwash which was placed on ice for approximately ten minutes or until snails 
were unresponsive to touch.  Each snail was then de-shelled and ground to a fine powder in 
liquid nitrogen using a mortar and pestle.  Ground snail tissue was then placed in 1.5ml 
plastic tubes and flash frozen in liquid nitrogen before storing at -80°C.  
To extract genomic DNA, approximately 3g of ground, frozen tissue was divided 
roughly equally between two 50mL Falcon tubes containing 40mL TE buffer, 1mL of 
10mg/mL Proteinase K (Sigma, #P4850), 2.4mL of 20% SDS and 3.4mL of water. The tubes 
were mixed gently by inversion and then incubated at 55°C for 15 minutes, then 45°C until 
the tissue has dissolved (this step may take overnight). After the tissue has dissolved, the 
tubes were placed on ice for five minutes then 31.2μL of 20mg/mL RNase A was added. The 
RNase A is then incubated at 37°C overnight. The following morning, an additional 31.2μL 
of RNase A was added and incubated another one hour.  
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After the incubation has finished, the contents of each tube were divided between four 
45mL falcon tubes and 14.6mL of ice-cold 5M potassium acetate was added to each. The 
tubes were incubated on ice for 20 minutes prior to spinning at 5250 x g for ten minutes. 
After centrifugation, the supernatant was then filtered through cheesecloth and divided 
equally between two 50mL falcon tubes. To precipitate DNA, 15mL of 2-propanol was then 
added to each tube and they were rocked gently on a shaker overnight at room temperature. 
The following morning, precipitated DNA was spooled on a hooked Pasteur pipette 
and transferred to a new 15mL tube. This tube was centrifuged quickly for 30 seconds and 
the supernatant was removed with a pipette. The pellet was then washed in 70% ethanol and 
air dried before resuspension in 5mL of Milli-Q water. To this, 5mL of ice-cold 5M lithium 
chloride was added and incubated on ice for one hour before centrifugation at 5250 x g for 15 
minutes. The supernatant was decanted into a fresh tube and 9μL of 20mg/mL RNase was 
added and allowed to incubate at 4°C overnight. The next morning, phenol-chloroform 
extraction and ethanol precipitation were preformed as in section 2.2.3. The genomic DNA 
pellet was resuspended in 2mL of milli-Q water and 1mL of TE buffer. The concentration of 
the extracted genomic DNA was measured using the NanoDrop spectrophotometer, and 
genomic DNA was diluted to an approximate concentration of 1μg/μL.  
 
2.5 Southern Blot Analysis 
 
In an attempt to examine the genomic structure of the LCavβ gene, Southern blotting was 
carried out. Lymnaea genomic DNA was digested with four restriction enzymes (EcoRV, 
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HindIII, EcoRI and XhoI), separated on a gel, transferred to a nylon membrane and probed 
using the double-stranded DIG-labeled DNA probes created previously. 
 
2.5.1 Restriction Digests of Genomic DNA 
 
Approximately 20μg of genomic DNA was digested with each of the four restriction 
enzymes- EcoRV, HindIII, EcoRI and XhoI. Digests were set up by adding 10μL of the 
appropriate 10X buffer (NEBuffer3 for EcoRI and EcoRV, NEBuffer2 for HindIII and XhoI; 
EcoRV and XhoI reactions were supplemented with 0.1mg/mL BSA) to the DNA. Reactions 
were diluted to 93μL with milli-Q water and 7μL of enzyme was added. These reactions 
were then incubated overnight at 37°C, followed by heat inactivation of enzymes at 80°C for 
20 minutes. After heat inactivation, 16μL of loading dye was added to each digest and 
samples were decreased in volume by approximately 75% using a DNA dehydrator with no 
heat. These samples were then run on a 1% agarose gel and visualized as in section 2.1.3. 
 
2.5.2 Transfer to Nylon Membrane 
 
To facilitate transfer of large genomic DNA fragments by capillary action to the nylon 
membrane, the agarose gel was first soaked in DNA degradation solution (0.5M NaOH, 
1.5M NaCl) twice for 15 minutes. The gel was then rinsed well in milli-Q water before 
soaking twice for 15 minutes in neutralization solution (3M NaCl, 0.5M Tris, pH7.5). The 
gel was then ready for transfer of the genomic DNA by capillary action. 
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 To achieve this, a square glass pyrex dish was filled halfway with 20X SSC buffer 
(3M NaCl, 30mM sodium citrate, pH 7.0) and a large platform (an upside down pipette tip 
box was used here) was placed in the middle of the dish, above the level of the buffer. Next, 
four pieces of blotting paper (VWR, #28298-020) were cut, each as tall as the height of the 
gel. Two of these pieces were then cut to match the width of the gel, while the other two 
were cut so they were 3-4 times as wide as the gel. The wide strips of blotting paper were 
centered over the platform and bent into the buffer to serve as a wick. On top of these sheets, 
the denatured and neutralized gel was placed face down. Next, a sheet of positively charged 
nylon membrane (Roche, #11 417 240 001) which was cut to the same size of the gel was 
placed directly on top of the gel, followed by the other two sheets of blotting paper. A large 
stack of paper towels was placed on top of the blotting paper and a weight (two textbooks) 
was placed on top of the paper towels. This setup was left at room temperature overnight. 
The following morning, the apparatus was disassembled and the DNA was cross-linked to 
the nylon membrane by exposure to UV light. 
 
2.5.3 Hybridization of DIG-labeled DNA Probes 
 
A hybridization oven was preheated to 40°C for the Southern blot of LCavβA+, and 37°C for 
LCavβB+ (these will be referred to as the hybridization temperature). In hybridization tubes, 
12mL of EasyHyb solution (Roche, #11 603 558 001) was pre-heated to the hybridization 
temperature. After pre-heating the EasyHyb solution, it was used to wash the nylon 
membrane for 30 minutes. During the wash, the DIG-labeled probes were heated to 95°C for 
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ten minutes, and then rapidly chilled on wet ice for another ten minutes. The entire volume of 
probe was then diluted in 20mL of EasyHyb solution and filter sterilized through a 0.4μm 
filter.  After the 30 minute incubation, the EasyHyb was decanted and replaced with the 
diluted DIG-labeled probe solution. The probe was allowed to incubate overnight at the 
hybridization temperature. 
The next morning, the probe solution was decanted and saved for later use. The nylon 
membrane was then washed twice with 20mL of low stringency buffer [2X SSC, 0.1%(w/v) 
SDS], first for 15 minutes, then 20 minutes at room temperature.  Next, the low stringency 
buffer was decanted and the membrane was washed twice in 20mL of High Stringency buffer 
[0.5X SSC, 0.1%(w/v) SDS], for 20 minutes. The first and second high stringency washed 
were at different temperatures. For LCavβA+, the membranes were washed at 55°C then 
65°C, whereas for LCavβB+ the membrane was washed at 50°C and 55°C. The high 
stringency buffer was then decanted and the membrane was washed in 20mL of wash buffer 
[100mM maleic acid, 150mM NaCl, 0.3%(v/v) Tween-20, pH 7.5] for one minute at room 
temperature, then blocked for one hour  at room temperature with blocking buffer [100mM 
maleic acid,  150mM NaCl, 1%(w/v) blocking reagent (Roche, #11 096 176 001)].  
During blocking, 1.5μL of sheep anti-DIG antibody conjugated to alkaline 
phosphatase (Invitrogen, # G-21079) was diluted in 7.5mL of detection buffer (0.1M Tris, 
0.1M NaCl, pH 9.5) to give a 1:5000 dilution. Upon completion of blocking, the blocking 
buffer was decanted and the diluted antibody solution was added. The antibody was allowed 
to incubate for 30 minutes at room temperature before it was removed.  
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Following incubation with the enzyme-conjugated antibody, the nylon membrane was 
placed on a shaker and washed twice in 80mL of wash buffer for 15 minutes at room 
temperature. The membrane was then washed in detection buffer for two minutes. During the 
washes a colour substrate solution was prepared by combining 10mL of detection buffer, 
45μL of 4-Nitro blue tetrazolium chloride (NBT; Roche, #11 383 213 001) and 35μL of 5-
bromo-4-chloro-3-indolyl-phosphate (BCIP; Roche, #11 383 221 001). After washing with 
the detection buffer, it was decanted and replaced with colour substrate solution. The 
membrane was allowed to incubate in colour substrate solution overnight in the dark (no 
shaking). The next morning, the colour substrate solution was decanted and the blot was 
briefly washed in Milli-Q water. A digital image was then taken of the blot using a desktop 
scanner. 
 
2.6 Determination of Genomic Structure of LCavβ Subunit N-terminus 
 
In order to better characterize the structure of the genomic region which surrounds the N-
terminus of LCavβ, PCR was performed on a genomic DNA template. This product was then 
isolated, cloned and sequenced. 
 
2.6.1 Primer Design and Polymerase Chain Reaction 
 
In order to amplify possible introns which could exist downstream of the LCavβB N-terminus 
by PCR, primers were designed to complement the distal portion of the N-terminus of 
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LCavβB (end-LBetaBexon) and the proximal portion of the SH3 domain (CBSB2 and 
CB5’Nco1b). The sequence of these primers is listed in table 2.1.  
In order to facilitate the amplification of a genomic region of unknown size, nested 
PCR was preformed with the Expand Long Template PCR System (Roche, #11 681 834 
001). Each 50uL reaction contained the following components 350uM of each dNTP, 300nM 
forward primer (end-LBetaBexon), 600nM reverse primer (CB5’Nco1b for primary PCR; 
CBSB2 for secondary PCR), 1X Expand Buffer 2, and 0.2uL Expand Long Template enzyme 
mix. Template for the primary PCR was 200ng of genmic DNA, while for the secondary 
PCR 1uL of the primary reaction was added. A negative control reaction containing no 
template was also included. Each reaction was then placed in an Eppendorf AG Mastercycler 
ep thermocycler and heated to 94°C for two minutes to denature the DNA. Next, the 
reactions underwent 30 cycles of heating to 94°C for 15 seconds, 56°C for 30 seconds then 
68°C for five minutes. From cycles 11 to 30, an additional 20 seconds was added to the 
elongation with each successive cycle. A final elongation of seven minutes at 68°C was 
added after the cycling was complete. 
 
2.6.2 Cloning of the LCavβ Genomic Fragment 
 
Cloning of the LCavβ genomic fragment was carried out using the TOPO XL PCR Cloning 
Kit (Invitrogen, K4750-10). All steps up to (but not including) transformation were carried 






Following TOPO cloning, plasmids were transformed into CopyCutter EPI400 
Electrocompetent E.coli cells (Epicentre Biotechnologies, #C400CH10). The CopyCutter 
cells were chosen for use because they are more efficient for cloning unstable DNA 
fragments since they maintain a low copy number until just prior to plasmid isolation. This is 
accomplished by the addition of CopyCutter Induction Solution just prior to plasmid 
isolation, which subsequently raises the copy number of the transfected plasmid (see below 
for more detail). 
 CopyCutter cells (50uL) were thawed on ice, before adding 1uL of the TOPO ligation 
reaction and mixing vigorously. The cell-plasmid mixture was then transferred to a sterile, 
pre-chilled 1mm Electroporation cuvette (VWR, #89047-206) and electroporated at 1200mV 
for 5ms using an Eppendorf 2510 electroporator. Cells were then immediately transferred to 
1mL LB medium and incubated in a 15mL tube at 37°C with shaking at 220rpm for one 
hour, before plating on LB agar plates containing 50µg/mL Kanamycin (OmniPur, #5880). 
Plates were then inverted and incubated overnight at 37°C. The following morning 12 
colonies were used to inoculate 12 tubes each containing 5mL of LB media supplemented 
with 50µg/mL of Kanamycin in a 60mL test tube and incubated overnight at 37°C while 
shaking at 350rpm. The following morning, overnight cultures were diluted to a final OD of 
0.2 in LB with Kanamycin and CopyCutter Induction Solution (diluted to 1X concentration) 
and then incubated for four hours at 37°C while shaking at 500rpm. Plasmids were then 
isolated by alkaline lysis as in section 2.2.7. 
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2.6.4 Screening of Plasmids by Restriction Digestion 
 
Isolated plasmids were screened for the presence of the LCavβ genomic fragment by 
digestion with the enzyme EcoRI, whose restriction sites bound the multiple cloning site of  
the TOPO cloning vector. One µg of plasmid was digested in EcoRI Buffer (diluted to 1X) 
and 0.5µL of EcoRI in a final volume of 10µL for four hours at 37°C. Results of the digest 
were then visualized on a 1% agarose gel as in section 2.1.3. Plasmids which appeared to 
contain the correct digestion pattern were sent for sequencing at Robarts Research Institute at 
the University of Western Ontario. Plasmids were sequenced in the reverse direction with the 
primer CBSB2 and an intron specific primer LBetaNdeI. 
 
2.6.5 Creation of Amino Acid Alignments and Phylogenetic Tree 
 
All amino acid alignments were created using ClustalW2 and data was exported and 
formatted using Excel 2007 (Microsoft Corporation). Alignments were then imported into 
PAUP 4.0 to generate a consensus gene tree using the Branch-and-Bound algorithm. The 
gene tree was tested for robustness in 100 bootstraps and displayed in TREEVIEW 1.6.6. 







Table 2.2: GenBank accession numbers of sequences used in amino acid alignments. 
Type Subtype Organism GenBank Accession # Reference 
Β βA Amphioxus EEN54426 Putnam et al., 2008 
  Aplysia californica EB291128 Moroz et al., 2006 
  Lymnaea stagnalis AF484087 Spafford et al., 2003 
  Loligo bleekeri AB069676 Kimura and Kubo, 2003 
 βB Aplysia californica EB255159 Moroz et al., 2006 
  Musca domestica  X78561 Grabner et al., 1994 
  Loligo bleekeri AB069677 Kimura and Kubo, 2003 
β1 β1a Homo sapiens AAA35631 Powers et al., 1992 
 β1b Homo sapiens AAA35633 Powers et al., 1992 
 β1c Danio rerio ABB05051 Zhou et al., 2006 
β2 β2.1 Danio rerio ABY19301 Ebert et al., 2008 
 β2a Homo sapiens AF423189 Colecraft et al., 2002 
 β2b Homo sapiens AF285239 Colecraft et al., 2002 
  Danio rerio DQ372945 Zhou et al., 2008 
 β2c Homo sapiens AF423190 Colecraft et al., 2002 
 β2cN1 Homo sapiens AY393860 Foell et al., 2004 
 β2d Homo sapiens AF423191 Colecraft et al., 2002 
 β2e Homo sapiens AF423192 Colecraft et al., 2002 
β3  Homo sapiens AY054985 Helton and Horne, 2002 
 β3a Danio rerio ABD34796 Zhou et al., 2008 
 β3b Danio rerio ABD34797 Zhou et al., 2008 
β4 β4a Homo sapiens AY054985 Helton and Horne, 2002 
  Danio rerio ABD34798 Zhou et al., 2008 
 β4b Homo sapiens AAB53333 Taviaux et al., 1997 
  Danio rerio ABD34799 Zhou et al., 2008 
     
 
2.7 Mammalian Cell Culture 
 
In order to assess the functional effects of LCavβA+, LCavβB+ and LCavβB-, it was necessary to 
express these proteins, in conjunction with LCav1 or LCav2 and α2δ subunits, in a 
heterologous expression system. Two cell lines were chosen for this purpose: Human 
Embryonic Kidney (HEK) 293T cells, and GripTite 293 MSR cells (Invitrogen, #R795-07).  
General electrophysiological and biophysical characteristics were studied using the HEK 
293T cells, while the GripTite 293 MSR cells were used in the fluorescent antibody-labeling 
experiments. The MSR cell line is a HEK derivative but can better withstand multiple wash 
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steps due to its superior adhesion to substrates. It should be noted that all manipulations 
involving living mammalian cells were preformed in a sterile biosafety cabinet. 
 
2.7.1 Complete Growth Media 
 
Both HEK and MSR cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; 
Sigma, #D5796) supplemented with 10% Fetal Bovine Serum (FBS; Sigma, #F1051) that 
had been heat-inactivated at 56°C for 30 minutes and 2.5mL of Penicillin-Streptomycin 
solution (5000 units of penicillin and 5mg streptomycin/mL; Sigma, #P4458). The complete 
HEK media (500mL) was further supplemented with 5mL of 100mM sodium pyruvate 
(Sigma, #S8636), while the complete MSR media was supplemented with 5mL of MEM 
Non-essential amino acids (Gibco, #11140). In all instances complete culture media was 
heated to 37°C in a water bath before use. 
 
2.7.2 Thawing Cells 
 
Aliquots of low-passage cells had been frozen in liquid nitrogen for long-term storage. To 
thaw the cells (procedure for both cell lines is the same, except where noted), one tube was 
removed from liquid nitrogen and rapidly thawed in a 37°C waterbath. During thawing, 
empty 50mL (25cm
2
) cell culture flasks were filled with 6mL of complete media. For HEK 
cells, two flasks were used; while three flasks were used for the MSR cells. When the frozen 
cells have thawed completely, the aliquot was divided evenly among the flasks and incubated 
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overnight at 37°C in a humidified 5% CO2 environment (these will be referred to as standard 
conditions). The next morning, cells were washed with fresh media and, for the MSR cells, 
72μL of 50mg/mL Gentecin (Gibco, #1070) was added to each flask. Cells were incubated 
under standard conditions until a confluency of 80-90% was reached, then the cells were 
subcultured. 
 
2.7.3 Subculturing Cells 
 
To subculture cells, the media was removed from the flask and cells were washed twice with 
phosphate buffered saline (PBS; 6.70mM KCl, 3.67mM KH2PO4, 10.82mM Na2HPO4-7H2O, 
342mM NaCl) that had been pre-warmed to 37°C. To detach cells, 1mL of 0.25% Trypsin-
EDTA (Sigma, #T4049) that had been heated to 37°C was added to the flask. The flask was 
then incubated at 37°C until the majority of cells had detached (to a maximum of five 
minutes). In the meantime, two new flasks were filled with 5.5mL of fresh complete media 
(these will be used for the next passage). Also, flasks of cells for transfection were filled with 
5mL of fresh complete media. If MSR cells were being subcultured, 72μL of Gentecin was 
added to each flask. Once the cells were detached, 5mL of fresh complete culture media was 
added and the cells were resuspended by pipetting up and down several times. The 
resuspended cells were then divided among the flasks so that each flask had a final volume of 
6mL, therefore the flasks to be used in the next passage were split 1:12, while the flasks to be 
transfected were split 1:6. These cells were then incubated under standard conditions. Cells 
were allowed to grow to 40-50% confluency prior to transfection. For all transfections (in 
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both cell lines), LCav1 or LCav2 were transfected with α2δ, and either LCavβA+, LCavβB+, 
LCavβB- or no LCavβ subunit. 
 
2.7.4 Transient Transfection of Human Embryonic Kidney Cells using 
Calcium Phosphate 
 
Transfection of HEK 293T cells was done using a calcium phosphate transfection protocol 
that was carried out by diluting 4μg of each plasmid to be transfected in 30μL of 2.5M CaCl2 
and sterile milli-Q water to 300μL. This was then added dropwise to 300μL of 2X HES 
buffer (280mM NaCl, 50mM Hepes, 1.5mM Na2HPO4-7H2O, pH 7.0). The mixture was then 
mixed well and allowed to incubate at room temperature for 20 minutes to allow for the 
formation of calcium phosphate crystals. 
 During the incubation, media was removed from the flask to be transfected and 
replaced with 5.4mL of fresh complete medium. After incubation, the calcium phosphate 
solution was added dropwise into the flask of cells. The flask was then incubated under 
standard conditions for eight to 16 hours. After eight to16 hours, the cells were washed twice 
with PBS pre-heated to 37°C and 6mL of fresh complete medium was added.  These cells 
were then incubated at 28°C in a humidified 5% CO2 atmosphere for two days before plating 





2.7.5 Transient Transfection of Human Embryonic Kidney Cells using 
Lipofectamine 
 
Due to lower transfection efficiencies, MSR cells were transfected using Lipofectamine 2000 
Reagent (Invitrogen, #11668-019).  Transfection with Lipofectamine was achieved by 
diluting 6.67μg of each plasmid to be transfected in 625μL of DMEM. In a separate tube, 
25μL of Lipofectamine was diluted with 625μL of DMEM. These tubes were then incubated 
at room temperature for five minutes before combining them, mixing well and incubating an 
additional 20 minutes. 
 During the incubation, the media was removed from flasks to be transfected, and 
replaced with 6mL of DMEM supplemented with FBS and non-essential amino acids (same 
concentrations as complete medium).  After the completion of the incubation, the transfection 
solution was added to the flask which was incubated under standard conditions for six hours. 
After six hours, the transfection media was removed and replaced with 6mL of complete 
media. These cells were then incubated at 28°C in a humidified 5% CO2 atmosphere for two 
days prior to plating (see section 2.6.7). 
 
2.7.6 Poly-L-Lysine Coating of Coverslips 
 
Prior to plating cells, sterile, round glass coverslips (Fisher Scientific, #12-545-80) were 
coated in poly-L-lysine. The coverslips were spread out in a single layer at the bottom of a 
large (100mm diameter) culture dish.  A dilute poly-L-lysine solution was made by diluting 
1.5mL of 0.1%(w/v) poly-L-lysine (Sigma, #P8920) in 13.5mL of milli-Q water. This 
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solution was poured over the coverslips and they were allowed to incubate at room 
temperature for one hour. After one hour, the poly-L-lysine solution was removed and 
coverslips were washed twice in 15mL of sterile water and then dried in a 56°C oven for two 
hours. After coating, coverslips were stored at 4°C for up to two weeks.  
 
2.7.7 Plating Cells Onto Coverslips 
 
Two days after transfection, both HEK and MSR cells were plated onto glass coverslips 
using the same method.  Media was removed from the flask and the transfected cells were 
washed twice with PBS before the addition of 1mL of trypsin, as in section 2.6.3. The cells 
were resuspended in 6mL of complete media and added to 60mm culture dishes containing 
the appropriate amount of complete media and four to six coverslips so as to give a split ratio 
of 1:3 and 1:4 for cells to be used in patch clamp experiments (HEK cells) and 1:6 for cells to 
be used for antibody staining (MSR cells). These dishes were then incubated at standard 
conditions for three to four hours before they were moved to 28°C in a humidified 5% CO2 
atmosphere. 
 
2.8 Western Blotting 
 
In order to verify that the LCavβ subunit proteins are being expressed by the HEK cell line, 
qualitative Western blotting was carried out five days after transfection. The rabbit anti- 
LCavβ antibody to be used was made by David Spafford and recognizes the epitope 
 
 50 
SLDEEKEALRRET, which is downstream of the N-terminus and is common to both LCavβ 
isoforms. 
 
2.8.1 Human Embryonic Kidney Cell Lysis 
 
Five days post-transfection, media was removed from the flask of transfected cells as well as 
a flask that had been mock transfected (no DNA present) and then the cells were washed 
twice with 2mL of PBS that had been warmed to 37°C. After washing, cells were 
resuspended in 250μL of warm PBS. HEK cells were then lysed by adding 250μL of 2X 
sample lysis buffer [80mM Tris (pH 6.8), 100mM DTT, 2%(w/v) SDS, 0.006%(w/v) 
bromophenyl blue, 15%(v/v) glycerol] that had been preheated to 95°C. Lysate was then 
incubated at 95°C for five minutes before loading on a gel. 
 
2.8.2 SDS-Polyacrylamide Gel Electrophoresis 
 
To separate proteins for Western blotting, proteins contained in the HEK cell lysate were 
separated by SDS- Polyacrylamide Gel Electrophoresis (SDS-PAGE). Proteins were run on 
two 5% acrylamide (resolving) gels- one of which will be used for blotting, while the other 
will be Coomassie stained. The resolving gels were made by adding 2.50mL of 30% 
acrylamide stock, 3.80mL resolving buffer [1.5M Tris (pH 8.8), 0.40% SDS(w/v)], 115μL of 
10%(w/v) ammonium persulfate, 7.50μL of TEMED and milli-Q water to 15.00mL. The 
resolving gel was poured between glass plates separated by a 1mm gap, topped off with 
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milli-Q water and allowed to polymerize. During polymerization the stacking gel was 
prepared by adding 1.28mL of 30% acrylamide stock, 1.88mL stacking buffer [0.5M Tris 
(pH 6.8), 0.40% SDS(w/v)], 80μL of 10%(w/v) ammonium persulfate, 7.50μL of TEMED 
and milli-Q water to 7.50mL. After the resolving gel had polymerized, the water was 
removed and the stacking gel was poured on top of the resolving gel, a comb (to make wells) 
was inserted and the gel was allowed to polymerize. 
 Once the gels were polymerized, they were submerged in running buffer [25mM Tris, 
19.2mM glycine, 1%(w/v) SDS] and the comb was removed. Next, 30μL of HEK cell lysate 
was loaded onto the gel as was 10μL of PageRuler Prestained Protein Ladder Plus 
(Fermentas, #SM1811) and the gel was run at 85V until proteins were appropriately 
separated. One gel was stained with Coomassie stain [0.1%(w/v) Coomassie Blue R-250, 
50%(v/v) methanol, 10%(v/v) acetic acid] and then de-stained with de-staining solution 
[8%(v/v) acetic acid, 12%(v/v) ethanol]. Digital images of the stained gel were taken using a 
desktop scanner. 
 
2.8.3 Transfer of Proteins to Nitrocellulose 
 
Once the total protein was appropriately separated by SDS-PAGE, the contents of the gels 
were transferred to a nitrocellulose membrane.  A glass pyrex dish was half-filled with 
transfer buffer [36.64mM glycine, 47.88mM Tris, 0.037%(w/v) SDS, 20%(v/v)  methanol, 
pH 8.3] and the gel was sandwiched between pads, and membranes in the following order 
(starting from the side that will face the negative electrode): pad, blotting paper (cut to fit gel 
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size), gel, 0.45μM nitrocellulose membrane (cut to fit gel size; Mandel, # W-10401196), 
blotting paper and another pad. The “sandwiches” were submerged in transfer buffer and the 
air bubbles were removed. The transfer apparatus (with an ice pack and stir bar), was then 
loaded with the “sandwiches” such that the nitrocellulose is between the gel and the positive 
electrode. The rig was then filled with transfer buffer and allowed to run overnight at 90mA 
(at 30V) while stirring. The following morning, the nitrocellulose membrane was temporarily 
stained with Ponceau stain to confirm that protein transfer has occurred and then de-stained 
with water.  
 
2.8.4 Membrane Blocking and Antibody Hybridization 
 
Before applying antibody, the nitrocellulose membrane must be blocked to reduce non-
specific interactions. Blocking buffer [10mM Tris, 100mM NaCl, 0.1% Tween-20(v/v), 
5%(w/v) skim milk powder] was added to the membrane in a shallow dish (enough to 
completely cover the nitrocellulose), placed on a shaker and allowed to incubate at room 
temperature for two hours. 
 After blocking, the membrane was washed five times with Tween-Tris-Buffered 
Saline [TTBS; 10mM Tris, 100mM NaCl, 0.1% Tween-20(v/v)] for five minutes at room 
temperature. Next, the primary antibody (rabbit anti-LCavβ) was diluted 1:2000 in blocking 
buffer and poured over the membrane after the last wash with TTBS. The primary antibody 
was incubated with the membrane overnight at 4°C. The following morning, the antibody 
was removed and the membrane was washed five times in TTBS for five minutes at room 
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temperature, and then once in blocking buffer for 15 minutes at room temperature. After the 
second block, the secondary antibody (Goat anti-rabbit IgG coupled to horseradish 
peroxidase; Invitrogen, #65-6120) was diluted 1:5000 in blocking buffer and added to the 
dish containing the membrane. The secondary antibody was incubated with the membrane 
for 30 minutes at room temperature before it was decanted. The membrane was then washed 
five times in TTBS for five minutes at room temperature. The membrane was then ready for 
chemiluminescent staining to detect the presence of LCavβ subunits. 
 
2.8.5 Antigen Detection 
 
LCavβ subunits were detected using the chemiluminescent stain ECL which was made by 
combining 20mL of freshly prepared solution one (2.5mM luminol, 396μM p-coumaric acid, 
100mM Tris, pH8.5) and 20mL of freshly prepared solution two (100mM Tris, 12μL of 30% 
H2O2, pH 8.5). Solutions one and two were combined, poured over the membrane and 
incubated for one minute at room temperature. The blots were then exposed to x-ray film 
(Kodak, #819 4540) for one minute in a darkroom before development using an automated 
developer. Films were then compared to nitrocellulose membranes and the ladder was 






2.9 Creation of EGFP-labeled Channels 
 
In order to visualize the subcellular localization of LCav1 and LCav2, both channels were 
fused with an EGFP molecule at the N-terminus. This was accomplished by cloning the 
channel into the vector pEGFP-C1 which encodes EGFP in reading frame with the insert 
(LCav1 and LCav2 in this instance) with no intervening stop codons. Described below is the 
procedure for the construction of LCav1-pEGFP-C1. LCav2-pEGFP-C1 was constructed in 
the same manner by Adriano Senatore. 
 
2.9.1 Restriction Digestions 
 
In order to obtain the necessary coding sequence of LCav1 for cloning, the plasmid LCav1-
pIRES was digested with the restriction emzymes XhoI and XmaI (New England Biolabs, 
#RO180S) as was the p-EGFP-C1 vector. These enzymes are chosen because they bound the 
LCav1 sequence in pIRES, and are present in the multiple cloning site of pEGFP-C1 (XhoI at 
the N-terminus; XmaI at the C-terminus). Approximately 10μg of each plasmid were diluted 
in 1X NEBuffer 4 supplemented with 0.1mg/mL BSA and 2.5μL each of XhoI and XmaI. 
The volume of both digests was 50μL and they were incubated at 37˚C overnight. The 
following morning, the digested pEGFP-C1 vector was dephosphorylated by supplementing 
the digest with 6μL of 10X Antarctic Phosphatase buffer, 2μL of milli-Q water and 2μL of 
Antarctic Phosphatase (New England Biolabs, #M0289). This reaction was incubated for 30 
minutes at 37°C. Following dephosphorylation of the vector, both the vector and the digested 
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LCav1-pIRES were run on a 1% agarose gel as in section 2.1.3. The bands representing the 
vector (5.3kb) and LCav1 (6.6kb) were excised and purified as in section 2.2.4.  
 
 
2.9.2 Ligation and Transformation into ElectroMAX Stbl4 Cells 
 
Ligations were carried out as described in section 2.3.4 with 50ng of pEGFP-C1 vector and 
insert to vector ratios (I:V) of 1:3, 1 and 3 and 0 (a negative control). The following day, 
ligation reactions were purified by phenol-chloroform extraction and ethanol precipitation as 
in section 2.2.3 and resuspended in 10μL of Milli-Q water. Due to the large size of the 
LCav1-pEGFP construct (11.9kb), plasmids were transformed by electroporation into 
ElectroMAX Stbl4 Competent Cells (Invitrogen, #11635-018). This was carried out by 
combining 2.5μL of purified ligation and 20μL of thawed cells in a 1mm electroporation 
cuvette and applying a 1200mV pulse for 5ms using an Eppendorf 2510 electroporator. 
Immediately following the application of the voltage pulse cells were added to 1mL of LB 
media and incubated at 37˚C while shaking at 450 rpm for 90 minutes before plating on LB 
agar supplemented with 50μg/mL Kanamycin. Plates were incubated at 37˚C for two days. 
Colonies from each ligation plate were used to inoculate 5mL of LB media supplemented 
with 50μg/mL Kanamycin and incubated at 37˚C for two days while shaking at 350rpm 
before plasmids were isolated as in section 2.2.7. In order to confirm the construct is indeed 
LCav1-pEGFP-C1, approximately 2ug of plasmid was digested with BamHI. Digests were 
10μL in volume, and contained 1X NEBuffer 3 supplemented with 0.1mg/mL BSA and 1μL 
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BamHI. After overnight incubation at 37˚C overnight, digests were run on a 1% agarose gel 
as in section 2.1.3. 
 
 
2.10 Antibody Staining of LCavβ    
 
Three days after plating, each coverslip of transfected MSR cells was transferred into its own 
well in a 24-well cell culture plate and washed twice with PBS that had been warmed to 
37°C. Cells were then fixed in freshly prepared 1% paraformaldehyde (diluted in PBS) for 
eight hours at 4°C. After fixation, coverslips were washed twice with PBS, and then 
permeabilized with 1% Triton X-100 (in PBS) for ten minutes at room temperature. Cells 
were then washed in TBS twice, once for 15 minutes at room temperature and once overnight 
at 4˚C before being blocked for three hours at 4°C in TBS (10mM Tris, 100mM NaCl, pH 
7.4) supplemented with 1%(w/v) BSA and 0.1%(v/v) Triton X-100. During blocking, rabbit 
anti-LCavβ antibody was diluted 1:4000 in TBS supplemented with 0.1%(w/v) BSA and 
0.1% Triton X-100. After blocking the antibody was applied to the coverslips and allowed to 
incubate overnight at 4°C on a shaker.  
 The next morning, the primary antibody was removed and coverslips were washed 
ten times in TBS supplemented with 0.1%(w/v) BSA and 0.1% Triton X-100. Following the 
washes, the secondary antibody (Goat anti-rabbit IgG antibody coupled to AlexaFluor 594; 
Invitrogen, #11072) was diluted 1:800 in TBS supplemented with 0.1%(w/v) BSA and 0.1% 
Triton X-100 and applied to the coverslips for 45 minutes at room temperature.  After 
incubation with the secondary antibody, cells were washed ten times in TBS and then 
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mounted on glass microscope slides using 15μL of FluorSave Reagent (Clabiochem, 
#345789) to help reduce fading of fluorescence. Slides were then imaged on a Zeiss 
Observer.Z1 fluorescent microscope with a 63X oil objective lens and digital images were 
taken of ten to 12 cells. Brightness and contrast were adjusted using Photoshop C2 version 
9.0.2 (Adobe). 
 
2.11 Electrophysiological Analysis of LCavβA+, LCavβB+ and LCavβB- 
 
The biophysical properties of LCav1 and LCav2 were assessed when co-expressed with α2δ 
and either LCavβA+, LCavβB+, LCavβB- or no LCavβ subunit using whole-cell patch clamp 
recording. Cells were recorded three to seven days after plating onto coverslips using an 
Axopatch 200B amplifier and Clampex 10.2 software (Axon Instruments). Calcium channel 
currents were measured in a 20mM Ba
2+
 external bath solution (Jarvis and Zamponi, 2001; 
20mM BaCl2, 40mM tetramethylammonium chloride, 10mM glucose, 64mM CsCl, pH7.2) 
and patch pipettes were filled with internal solution (Jarvis and Zamponi, 2001; 108mM 
cesium methane sulfonate, 4mM MgCl2, 9mM Hepes, 9mM ethylene glycol tetraacetic acid, 
pH 7.2). During all recording sessions, cells were maintained at a holding potential of -
100mV. Prior to recording, a test step to peak current (10mV for LCav1 or 30mV for LCav2) 
was preformed to indicate if the cell was producing a current and if the state of the patch was 




2.11.1 Current-Voltage Relationship and Steady-State Inactivation Analysis 
 
The current-voltage (IV) relationship was assessed by stepping cells from -100mV to             
-50mV for 450ms and then increasing the voltage step by 10mV in successive sweeps until 
reaching a potential of 50mV. To analyze the effect of LCavβ subunits on the steady-state 
inactivation of the channels cells were stepped from -100mV to peak voltage for 150ms, then 
allowed to recover for 1s before being held at -100mV until all channels had reached 
inactivation (this conditioning step may take up to 15 seconds) then immediately stepping to 
peak again for 150ms. In successive sweeps, the conditioning potential used to inactivate 
channels was increased by 10mV each time until reaching 30mV. 
 
2.12 Analysis of Electrophysiology Data 
 
For all recordings, leak subtraction was preformed offline and data was filtered using a 
500Hz Gaussian filter using Clampfit 10.2 software (Axon Instruments) before further 
analysis. 
 
2.12.1 Activation and IV Curves 
 
To create activation and IV plots, data was imported into Excel (Microsoft Corp.) where the 
current (I; in pA) at each voltage step was normalized to peak current (Imax; in pA) for that 
cell. Each normalized IV relationship was plotted and the individual reversal potentials (Erev; 
in mV) were determined by calculating the y-intercept of the linear portion of the IV curve 
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(+20 to +40 for LCav1; +30 to +50 for LCav2). The reversal potential represents the 













) through the 
VGCCs. The conductance (rate of ions flowing through the channel) was then determined for 
each voltage step using the equation below (equation 1): 
G= (I/Imax)/(V-Erev) 
where G represents conductance (pS) of the channel and V represents the test voltage (mV). 
For each trace maximum conductance (Gmax) was then determined. The mean and standard 
error of the mean (SEM) were calculated for (I/Imax), Erev and Gmax.  
Activation plots were created using Origin 8 software (as were all plots; OriginLab) 
by importing IV data and then performing a Boltzmann transformation using the equation 
below (equation2): 
Activation = I/(V-Erev) 
The Boltzmann-transformed data was then normalized and the a scatter of normalized 









where V0.5 and Ka represent the half-activation voltage and slope factor of the activation 
curves, respectively. The half-activation potential is the voltage at which 50% of the maximal 
number of channels are open. The slope factor of the activation curve is a value that 
represents the delay of channels transitioning from the closed to active (open) position.  
These values were determined by the Origin software.  A1 and A2 equal one and zero, 
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respectively, and correspond to maximum and minimum values allowed in the curve fit. The 
normalized activation data [(I/Imax), V0.5, Ka] was then averaged and the SEM was 
determined. The mean data was then plotted and a curve was simualted using these 
parameters and equation 3. 
IV plots were created by plotting voltage against mean (I/Imax)±SEM and then fitting 
with an Ohmic-Boltzmann curve using the following equation (equation 4): 








2.12.2 Steady-State Inactivation Curves 
 
Steady-state inactivation values were determined by dividing the current after the 
inactivating (conditioning) pulse by the current prior to the inactivating pulse. Each data set 








where V0.5 and Ki represent the half-inactivation voltage and the slope factor of inactivation, 
respectively. The half-inactivation potential is the voltage at which 50% of the channels are 
available and the other 50% of channels have transitioned from the open to the inactivated 
state. A1 and A2 are parameters that represent the maximum and minimum and are equal to 
one and zero, respectively. The values of V0.5 and Ki (determined by Origin) and (I/Imax) were 
then averaged and the standard error of each mean was calculated. The mean steady-state 
activation data was then plotted ± SEM and this data was used to simulate a Boltzmann curve 




2.12.3 Gating Kinetics 
 
All kinetic analysis was performed using Clampfit 10.0 software and plotted using Origin 8. 
Due to the much slower kinetics of LCav1 channels, time-dependent methods were used in 
the kinetic analysis, where as statistical methods were used in the kinetic analysis of LCav2. 
 For LCav1, time to peak after the start of the depolarization was determined as a 
measure of activation kinetics which describes the latency in opening of channels in whole-
cell currents. The total population of channels is likely to show some delay between 
depolarization and activation as the α1 subunit undergoes conformational changes. In order to 
compare the relative inactivation of each LCav1 dataset the fraction of current remaining 
350ms after peak (R350) was determined. Larger R350 values correspond to a channel which 
has slowed inactivation kinetics, since there is relatively larger fraction of the current 
remaining at a given time. Conversely, channels which display rapid inactivation will have 
low R350 values. Slowed inactivation kinetics can lead to channels being open for longer 
durations and therefore allow more ions through the pore. 
 Tau values for activation and inactivation were used to compare the kinetics of LCav2 
channels. To find the tau values, the portion of the curve from the start of the inward current 
to peak, or from peak until the channels had inactivated, was isolated for analysis of 
activation or inactivation kinetics, respectively. These segments were then curve fit with a 
monoexponential equation for activation and a biexponential equation for inactivation using 
pClamp 10.0 software. The tau value represents the point at which two thirds of the 
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exponential curve (that was fit) has decayed. Therefore, higher values for the tau of 
activation represent whole-cell currents that reach peak from a closed state more rapidly than 
those with lower values; slower transition of the total population of cells from an activated 
state to an inactivated state will lead to increasing the tau of inactivation. The second tau 
value for inactivation was chosen for analysis as this represents the fast component of 
inactivation, which occurs in the first 100ms or so after peak is reached. Mean tau values ± 
SEM were then plotted in Origin 8. 
 
2.12.4 Statistical Analysis 
 
All data derived from patch clamp recording was statistically analyzed using one-way 
analysis of variation (ANOVA) tests freely available online at <http://www.danielsoper.com/ 
statcalc/calc43.aspx> (Cohen et al., 2003; Ferguson and Takane, 2005). Statistical 






Alternative splicing has been reported for all Cavβ subunits and their splicing appears to be 
conserved in the N-terminus and HOOK domain when invertebrates (mollusks and squid), 
fish and mammals are compared. As seen in figure 3.1, the amino acid sequence similarity 
between invertebrate Cavβ subunits and all four mammalian Cavβ subunit genes is very low 
in the N-terminus and HOOK regions. The similarity in these regions is low because of 
extensive alternative splicing. These alternative splice isoforms have bearing on the function 
of Cavβ subunits, but the details of their roles in VGCC modulation are not clear because of 
the lack of accessible models for analyses.  It is the goal of this project to isolate and evaluate 
Cavβ subunit splice isoforms in the pond snail Lymnaea stagnalis, an amenable model for 
molecular and electrophysiological study.  Previously, a full length Lymnaea Cavβ subunit 
(LCavβA; Genbank Accession # AF484087.1) has been reported, which forms part of a 
functional voltage-gated calcium channel complex when transfected in HEK 293T cells with 
the primary α1, and auxiliary α2δ subunits (Spafford et al., 2004).  The following chapter 
outlines the identification, cloning and characterization of two novel Cavβ subunit splice 









Figure 3.1: Running window of amino acid similarity among invertebrate and rat homologs. Note the 
highly conserved structural core of β subunits involving Src Homology 3 (SH3) and guanylate kinase (GK) 
domains.  Highly divergent exons are present in the N-terminus, HOOK and C-terminal domains . Domain 
boundaries are assigned according to the rat β3 gene (Birnbaumer et al., 1998). A similarity score closer to one 
indicates that the amino acid sequences are closer in identity to one another at that location.  GenBank (gi) 
sequences for analyses includes rat isoforms: 1b, 8393060; 2a, 16758716; 3, 1705686; 4, 423788; Lymnaea 
stagnalis, 29378325; Loligo bleekeri 19911801; Drosophila melanogaster 6646874; C. elegans 17506267; 
Schistosoma mansoni 15283999; Cyanea capillata 2654496. Alternatively spliced isoforms exist for regions of 
the N-terminus and exon 7of the HOOK domain. Adapted from Spafford, J.D. et al. (2004). J. Biol. Chem. 279, 











3.1 Screening of cDNA Library 
 
Many Cavβ subunit splice isoforms have previously been uncovered using degenerate 
primers to screen cDNA libraries. Using degenerate primers in the highly conserved SH3 
region and anchoring universal primers EV2 and T77 on the vector, a parasitized cDNA 
library made from Lymnaea cerebral ganglia was screened and several products were 
identified. Several PCR products were produced that differed in size from the known 
isoform, LCavβA, which would produce a product that is 326bp in length. The agarose gel of 
these products (from library fractions C, M, P, R,  U, V, and W) can be seen in figure 3.2. 
After purification, there was only enough template remaining to sequence the products from 
fractions C, M, R, and W.  
After analysis of the sequence, it was determined that the product from fractions R 
and W were truncated versions of LCavβA, and fraction C did not sequence. However, the 
sequence from fraction M appeared to contain a novel N-terminus. This was determined by 
aligning the new sequence with the known sequence of LCavβA (figure 3.3), and noting that 
the sequence of the 3’ end of the fragment was perfectly aligned, and then as the sequence 
reached the 5’ end there was total divergence from the sequence of LCavβA in the final 111bp. 
At the 5’ end of the 111bp there was also a start codon (ATG), indicating that a functional 
LCavβ subunit could be expressed from this sequence. This new N-terminal isoform was 
termed LCavβB. Cloning of this novel N-terminus into the full-length LCavβ subunit was 






Figure 3.2: Results of cDNA library screening for novel LCavβ N-termini. Lanes N1 and N2 represent the 
negative control PCRs from the primary and secondary reactions, respectively. LCavβA would be expected to 
produce fragments of 326bp in length. The sample in lane M was sequenced and found to contain the novel N-

















Figure 3.3: DNA sequence alignments of the unique N-terminal isoforms of LCavβ subunits. Nucleotide 
and amino acid sequence alignment of the N-termini of LCavβA (red) and LCavβB (blue). Coding sequence is 
outlined by a black box. Identical DNA sequence are indicated by dark outlined gray boxes and similar ones by 
lighter colored gray boxes.  Note that the only sequence shared between the two isoforms is a short 13 bp 
“CATGTGAwCATAC” motif in the 5’ untranslated region, which may be a common upstream DNA regulatory 
element for LCavβ subunits. Downstream of the sequence shown above, until the HOOK region, there was 








3.2 Cloning of LCavβB into pMT2SX(R) 
 
The N-terminus of LCavβB was amplified from fresh cDNA so that it could be cloned into a 
full-length LCavβ subunit in a mammalian expression vector. The digested product of the 
amplification, as well as LCavβA-pMT2SX(R) vector can be seen in figure 3.4. The N-terminal 
fragment was 1014bp in length, while the PMT2SX(R) vector and C-terminus of the LCavβ 
subunit was 5.4kb in length. The correct clone of LCavβB, was confirmed by restriction 
digestion with SalI and BlpI (as seen in figure 3.5) prior to sequencing, although a strange 
doubling of bands was noted.  Sequencing of the clones revealed the presence of two LCavβB 
isoforms. Comparison of the sequence of the clones revealed that there is a 21bp insert 
present in the HOOK region of one LCavβB clone, but not the other. The coding sequence of 
LCavβB is shown in figure 3.6, where the novel N-terminus and the HOOK insert are shown 
in blue and red, respectively. The clones with, and without, the insert were called LCavβB+ 
and LCavβB-, respectively. LCavβA also contained the 21bp HOOK insert, and so it will be 
referred to as LCavβA+.  
 
3.3 Southern Blotting 
 
There are four Cavβ subunit genes in vertebrates, and usually only one is found in 
invertebrates (although an exception is found in Schistosomes, where two different Cavβ 
subunit genes are found). As seen in figure 3.7, when a phylogeny of vertebrate and 




Figure 3.4: Fragments for cloning of LCavβB into pMT2SX(R). All DNA fragments have been digested with 
NotI and BlpI to facilitate cloning. The middle lane (red box) contains the digested PCR fragment containing 
the N-terminus of LCavβB (1.01kb). The right lane (yellow box) contains PMT2SX(R) and the C-terminus of 












Figure 3.5: Confirmation of  LCavβB clones by restriction digestion. Potential clones were digested with SalI 
and BlpI. Complete digestion of LCavβB-pMT2SX(R) with these enzymes would be expected to produce two 
products of 1.0kb and 5.4kb in length. The doubling of bands seen above was not observed consistently and 
cannot be explained. Clones were also later confirmed by sequencing to be LCavβB+ (*) and LCavβB- (**). There 








Figure 3.6: Complete coding sequence of LCavβB. The novel N-terminus of LCavβB is shown in blue, while 
the optional insert that is found in the HOOK region is underlined and highlighted in red. The optional HOOK 









Figure 3.7: Phylogeny of invertebrate and rat Cavβ subunits. Protein sequences of LCavβ and other Cavβ 
subunit homologs were aligned and used to generate a consensus gene tree using the Branch-and-Bound 
algorithm. The gene tree was tested for robustness in 100 bootstraps which are displayed at the branch node. 












invertebrates like Loligio (squid) and Drosophila, while the four mammalian homologs are 
grouped together. In order to characterize the copy number and confirm that there is only a 
single Cavβ subunit homolog found in Lymnaea, Southern blotting experiments were carried 
out. First, small, unique fragments of each N-terminal sequence were successfully cloned 
into a pBluescriptSK(+) vector and the presence of the correct insert was confirmed by 
sequencing. Using these clones as template, DIG-labeled DNA probes were produced and 
purified as seen in figure 3.8. When compared to fragments amplified in the absence of DIG-
labeled dUTP, the DIG-labeled probes appeared slightly heavier due to the presence of the 
DIG, which increases the molecular weight of the probe (figure 3.8).  
Prior to restriction digestion, Lymnaea genomic DNA extracts were run on a gel to 
ensure that there was no (or little) degradation of the DNA and no RNA was present. As seen 
in figure 3.9, the DNA remained undegraded upon completion of the extraction and therefore 
was suitable for use in Southern blotting. This DNA was then fully digested with the chosen 
restriction enzymes as seen in figure 3.10. After transferring the restriction digests to 
positively-charged nylon membranes (which bind DNA), they were hybridized with the DIG-
labeled DNA probes to produce the blots seen in figure 3.11. The blot of LCavβB (figure 
3.11B) shows a single, dark band in each lane, indicating that this gene is a single-copy gene; 
however the blot of LCavβA+ (figure 3.11A) was not so clear. Several attempts under various 
conditions were made to produce a clear Southern blot with no success.  The blot of LCavβA+ 
had two faint bands in each lane, possibly indicating the presence of an intron which divides 
the region that is recognized by the DIG-labeled probe. This is likely the case, given that 




Figure 3.8: Synthesis of DIG-labeled DNA probes for Southern blotting of LCavβ  subunit isoforms. The 
positions of positive control (non-DIG) reactions were highlighted with red boxes due to low yield. Note that 
the molecular weight of DIG-labelled DNA probes is slightly higher than positive controls due to the increased 








Figure 3.9: Uncut genomic DNA to be used for Southern blot analysis of LCavβ. Note that the genomic 






Figure 3.10: Digested genomic DNA for Southern blot anaylsis of LCavβ. Extracted genomic DNA was fully 








Figure 3.11: Southern blots of LCavβ. (A) Southern blot of LCavβA+ shows multiple faint bands in each lane 
of the blot. The double banding is caused by the presence of an intron which divides the N-terminus of LCavβA+ 
between two exons. (B) Southern blot of LCavβB+
 shows discreet single bands in each lane, consistent with a 










section 3.4 and figure 3.15). To further investigate the genomic structure of the LCavβ 
subunit, genomic sequencing of the N-terminus was carried out. 
 
3.4 Genomic Analysis of the Lymnaea Cavβ Subunit 
 
In order to characterize the genomic structure and evolution of the LCavβ subunit, several 
attempts were made to sequence the genomic region between the N-terminal exons. A PCR 
product of approximately 3.0kb in length was produced using genomic DNA as the template 
and primers which target the C-terminal end of the B exon (called end-LBetaBexon) and the 
N-terminal end of the conserved SH3 domain (CBSB2) shared by both LCavβA and LCavβB 
(figure 3.12).  This product was then cloned into the pCR XL-TOPO vector (figure 3.13) and 
sequenced, leading to the proposed genomic structure illustrated in figure 3.14A.  
Sequencing of the cloned fragment revealed the presence of three exons (labelled B, C and D 
in figure 3.14B and C), separated by two introns. Just upstream of the CBSB2 primer site, the 
SH3 domain is divided by a 2263bp intron that is bounded by putative donor (5’-GTAAAG) 
and acceptor (5’-TTTCAG) sites to facilitate splicing. Exon C (39amino acids), which is 
common to both N-terminal LCavβ subunit variants, can be found upstream of this intron 
preceded by a 516bp intron. Again, putative donor (5’-GTAATA) and acceptor (5’-
ACACAG) sites were located in this 516bp intron indicating that splicing was indeed 
possible in this region. Finally, as the sequence continues upstream the distal portion of the 
unique N-terminus found in LCavβB is reached (this will be referred to as exon B).  No 




Figure 3.12: Secondary genomic PCR of LCavβ N-terminus. Primers CBSB2 and end-LBetaBexon were 
employed to produce a secondary PCR product of approximately 3.0kb in length from a genomic DNA 













Figure 3.13: Cloning of  LCavβ N-terminal genomic fragment. Plasmids raised in 
CopyCutter cells were isolated and digested with EcoRI (left lane), removing the LCavβ 











Figure 3.14: Proposed genomic structure of the LCavβ subunit N-terminus mimics the genomic structure 
of  mammalian Cavβ subunits. (A) The proposed genomic structure of the LCavβ N-terminus resembles that of 
mammalian Cavβ2 and Cavβ4 genes. Both LCavβ2 and LCavβ4 contain two exons (homologous to putative 
exons  A1 and A2, yellow and green) encoding homologs of LCavβA , followed by single short N-terminal 
exons (red, blue or purple) which do not resemble one another. A conserved exon (blue; beginning GSA…) is 
found in all Cavβ subunits follows. Modified from Vendel, A.C. et al. (2006). Protein Sci. 15, 2, 378-383. (B) 
Introns (black) between exons B (red) and C (blue), and C and D (blue) contain donor and acceptor sites to 
facilitate splicing of these exons. (C) Schematic representation of intron structure of the N-terminus of LCavβ. 
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Given these findings, and in comparison to what is observed in mammals, fish and 
other invertebrates (figure 3.15), we propose that the N-terminal exon of LCavβA is upstream 
of the exon B sequence, and not part of a separate gene. This is supported by the fact that 
there was no divergence in the nucleotide sequence between LCavβA and LCavβB outside of 
the N-terminus and HOOK regions. All of the LCavβB clones made from cDNA were 
sequenced in the reverse direction with the primer BlpIbb, which covered the N-terminus, 
SH3, and HOOK domains (approximately 1kb downstream from the N-terminus). The 
sequence was then compared to the known sequence of LCavβA. In exon C and downstream 
regions, no sequence divergence was noted between LCavβA and LCavβB, with the exception 
of the optional seven amino acid insert in the HOOK region.  If the N-termini of LCavβA and 
LCavβB were products of different genes, it is likely that some divergence of downstream 
sequence at the nucleotide level would have taken place by random mutation.  
The genomic structure of other Cavβ subunit genes were compared in an alignment of 
the N-terminus of LCavβA and LCavβB with several invertebrate and vertebrate Cavβ subunit 
homologs (figure 3.15). It was immediately clear that there are homologs of both LCavβA and 
LCavβB found in another mollusc, Aplysia californica. Also, the N-terminal amino acid 
sequence of LCavβA  was conserved to a higher degree among all species, while the sequence 
of LCavβB seemed to have diverged from vertebrate Cavβ subunits to a greater extent.  The N-
terminus of LCavβA, in fact, appeared to be constructed from two exons based on comparison 
with the vertebrate homologs (these will be referred to as exons A1 and A2). Exon A1 did 
not show a high degree of conservation, with exons varying in length and composition 




Figure 3.15: Amino acid alignment of N-terminus of invertebrate and vertebrate LCavβ subunits. 
Conserved residues are highlighted in red, blue or grey for exons A1/A2, B or C, respectively. Thick black lines 
represent exon boundaries, while the thin black line in molluscan CavβB represents the starting point of the 
known N-terminal genomic sequence. Underlining represents palmitoylation sites.  Note that the amino acid 
composition of exons A1 and B are highly variable between moluscs and non-molluscs, while exons A2 and C 
are more highly conserved among invertebrates and vertebrates. GenBank accession numbers of the aligned 









variable exon A-1 (M…Q) intron conserved exon A-2 (GKG…FIRQ) intron exon C (GSADSY…)
-
LCavβ-A M A L A S S Q F Q E F V E T A L P A V S Q - - G K G G K R K G - R F N K R S D G S F S - - D - S S N S - F I - R Q G S A D S N Y S Q P S -
Aplysia β-A M A L A P T Q F Q E F V E T V M P S A S Q - - G K G G K R K G - K F N K R S D G S F S - - D - S S N S - F I - R Q G S A D S N Y S Q P S -
squid β-A M A R P S S H Y Q E L D G D M Q T V T Q - - G K G S K R K G G K F - K R S D G S F S - - D - S S N S - F I - R Q G S A E S T C S Q P S
Amphioxus β-A M A R V P P R E Y E L E T D L Y G V N Y P Q - - S K G A K R R G P - F - K P S D G S F S - - D T S D N S - I I - R Q G S A E S Y N S R P S
human β-1b M V Q K T S M S R G P Y P P S Q E I P M E V F D P S P Q - - G K Y S K R K G - R F - K R S D G S T S S - D T T S N S - F V - R Q G S A E S Y T S R P S -
human β-2d M V Q R D M S K S P P T A A A A V A Q E I Q M E L L E N V A P A G A L G A A A Q S Y G K G A R R K N - R F - K G S D G S T S S S D T T S N S N F V - R Q G S A D S Y T S R P S
human β-2c M N Q G S G L D L L K I S Y G K G A R R K N - R F - K G S D G S T S S S D T T S N S N F V - R Q G S A D S Y T S R P S
zebrafish β-3 M V Q V K M S K S S A D P L S G V E S A S Q S H Y F Q L P R K L P K R K G - R F - K R S D G S T S S - D T T S S - - F I K R Q G S A D S Y T
human β-4b M S S S S Y A K B G T A D G P H S P T S Q V A R G T T T R R S - R L - K R S D G S T T S T S - - - - - - F I L R Q G S A D S Y T S R P S -
variable exon B2 exon C (GSADSY…)
LCavβ-B M R I K A G E T N G L Q G N M E - S N P I M H E T L P Q G R M G R L K K E V T S G L S D I D S L G S A D S N Y S Q P S -
Aplysia β-B M R I K T E G V H G I P G S M E N S S P V M H E T L P Q G R M G R L R K E A T S G L S D I D S L G S A D S N Y S Q P S -
squid β-B M Q S L L G L S C V G P I V P I K G S A E S T C S Q P S
housefly β-B M K K L H I G G G K H K S K S Y K P F K N K R R G S A D S N Y S Q P S
human β-2a M Q C C G L V H R R R V R V S Y G S A D S Y T S R P S -
human β-2b M L D R R L I A P Q T K Y I I P G G S A D S Y T S R P S
human β-2e M K A T W I R L L K R A K G G R L K N S D I C G S A D S Y T S R P S
human β-3 M Y D D S Y V P G F E D S E A G S A D S Y T S R P S L
human β-4a M Y D N L Y L H G I E D S E A G S A D S Y T S R P S -
a a a a a b b b b
variable exon B 
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among all species. Exon A2 contained several regions rich in charged amino acids (lysine, 
argenine and aspartic acid) that were highly conserved among molluscs, mammals and fish 
perhaps suggesting that this region may be of physiological significance. It was also 
interesting to see that homologs of exons A1 and A2 could be found in all vertebrate Cavβ 
subunit genes (Cavβ1 , LCavβ2,,Cavβ3 and Cavβ4). Strangely, homologs of exons A1 and A2 are 
present in zebrafish Cavβ3, however, in mammals these exons appeared to have been lost in 
the Cavβ3 gene, leading to the hypothesis that the loss of the CavβA N-terminus in Cavβ3 
occurred after the divergence of mammalian and fish Cavβ subunits.  
 When we compared the protein sequence of LCavβB to other molluscan and 
vertebrate Cavβ genes (figure 3.15), it was evident that snails like Lymnaea and Aplysia 
contained a much longer N-terminus than non-molluscs including squid (Loligo), another 
invertebrate. In squid, fish and mammals the N-terminus of the LCavβB homologs were 
contained in a single exon. Consistent with what is found in mammals, the single discreet 
bands observed in the Southern blot of LCavβB (figure 3.11B) suggests that there is no intron 
dividing exon B in molluscs. Although not found in the cDNA library, shorter isoforms of 
LCavβB were possible as methionine residues were found in the N-terminus at positions 15, 
21 and 30. These residues could potentially serve as start codons for the production of shorter 
variants of LCavβB producing N-termini that would be 32, 26 and 17 residues long, 
respectively (figure 3.15). These truncated variants would have been similar in length to most 
non-molluscan homologs, which varied from 15 to 24 amino acids. Contrary to the relatively 
high degree of conservation that was observed in the N-terminus of CavβA homologs among 
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species, there was surprisingly little conservation observed between molluscan CavβB and 
isoforms found in other species. 
Aside from the N-terminal region, LCavβ also contained alternative splicing in the 
HOOK region. In order to study the patterns of evolutionary conservation found in this 
domain, an amino acid alignment of the invertebrate, mammalian and fish HOOK regions 
was constructed (figure 3.16).  The alignment of the HOOK region revealed some interesting 
patterns of conservation, leading to the hypothesis that that there may have been a primordial 
form of the HOOK domain shared among invertebrates, mammals and fish. As seen in figure 
3.16, the HOOK region is encoded by exons 6 and 7. Exon 6 does not show a high degree of 
conservation and, not surprisingly, it was noted that in this region conservation was found 
mostly within closely-related species- the invertebrates (Lymnaea and Loligo) seem to group 
together, as do vertebrate Cavβ1 and Cavβ2 genes, while Cavβ3 and Cavβ4 appear to be unique. 
The length of exon 6 was found to be quite variable, but was always serine-rich and always 
ended in a -TPPXX motif were X= T, P, S or A (except in zebrafish Cavβ4).  
 The second exon of the HOOK region, exon 7, is alternatively spliced and can be 
highly variable in length (figure 3.16). In vertebrates (fish and mammals), exon 7 is formed 
from one of three mutually exclusive exons termed 7A, 7B or 7C (figure 3.16; Foell et al., 
2004). Depending on which exon is expressed, the size of the HOOK region will differ 
substantially. Long isoforms, of 45 or 52 amino acids in human Cavβ1a or Cavβ2d, 
respectively, are formed by the inclusion of exon 7A, which ends with the motif -PFFKK that 
is conserved in all species studied. In a unique variant of human Cavβ2, exon7C (21 residues 
long) is included in place of exon 7A or 7B, leading to a moderately sized HOOK region.  
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EXON 5 EXON6 EXON 7B EXON 7A / 7C
Lymnaea+ L E N L K T Q S G G G G R Q G K L Y T S K T . . N S S S N I D N L L N S S K P S N S R G S T P P T P G V Q F V S P G I E E T Q N G V D S N V G E D S D S L G N S K S S K A S I T P P T K E K R K P F F K K S E S A
Loligo B L E N L K L Q L T S S G K G A K F Y G . K V . . N S P S N I D N . . . . . . . . F S R V S T P P T P E C M F L . . G I D G D H N G V D S N V G E D S D S L G N V R T S K P N I T P P T K E K R K P F F K K S E N I
Lymnaea- L E N L K T Q S G G G G R Q G K L Y T S K T . . N S S S N I D N L L N S S K P S N S R G S T P P T P . . . . . . . G I E E T Q N G V D S N V G E D S D S L G N S K S S K A S I T P P T K E K R K P F F K K S E S A
Loligo A L E N L K L Q L T S S G K G A K F Y G . K V . . N S P S N I D N . . . . . . . . F S R V S T P P T P . . . . . . . G I D G D H N G V D S N V G E D S D S L G N V R T S K P N I T P P T K E K R K P F F K K S E N I
human 2d 7A L E N M R L Q H E Q R A K Q G K F Y S S K S G G N S S S S L G D I V P S S R K S . . . . . T P P S S . . . . . . . A I D I D A T G L D A E E N D I P A N H R S P K P S A N S V T S P H S K E K R M P F F K K T E H T
zebrafish2.1 7A L E S S R L R Q E Q R A K Q G R F Y S S K S G A N S S S S L G D I V S N S R K S . . . . . T P P S S . . . . . . . A V D I D A A G L D A E E S D P P L H Q R S P K A S P N T V I S P L A T E K R M P F F K K T E H A
human 1a 7A L D S L R L L Q E Q K L R Q N R L G S S K S G D N S S S S L G D V V T G T R R P . . . . . T P P A S G N E M T N L A F E L D P L E L E E E E A E L G E Q S G S A K T S V S S V T T P P P H G K R I P F F K K T E H V
zebrafish 1c 7B L E S T R Q L Q E Q R M R Q N R L S S S K S G G S S S L D V A T G A R R P . . T P P G T G G P A K Q K Q K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M E H V
human 1b 7B L D S L R L L Q E Q K L R Q N R L G S S K S G D N S S S S L G D V V T G T R R P . . . . . T P P A S A K Q K Q K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T E H V
zebrafish 2b 7B L E S S R L R Q E Q R A K Q G R F Y S S K S G A N S S S S L G D I V S N S R K S . . . . . T P P S S A K QW Q K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T E H A
human 3a 7B L E S I R L K Q E Q K A R . . . . . . R S . . . . G N P S S L S D I G N R R S . . . . . P P P S L A K Q K Q K Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A E H V
zebrafish 3b 7B L E A M R I K Q E Q K A A . . . . . . Q R . . . . . . K M G N A S S G GW R S . . . . . T P P S A A K Q K Q K Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T E H V
zebrafish 3a 7B L E A M R L K Q E Q K Q Q . . . . . . R K S G N S S S S L G D M V S G GW R S . . . . . T P P S A A K Q K L K Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T E H I
human 4 7B L E N I R I Q Q E Q K R G . . R F H G G K S S G N S S S S L G E M V S G T F R A . . . . . T P T S T A K Q K Q K V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T E H I
zebrafish 4b 7B L E N I R A Q L E Q K K S . . . R V Q G K S S G S S S S S L G . . . . . . . . . . . . . . D V M S S G K Q K Q K V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T E H V
zebrafish 4a 7B L E N I R L Q Q D Q K R G . . R F H G . K S S G N S S S S L G E M V S G T F K P . . . . . N P A S A G K Q K Q K V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A E H I
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Figure 3.16: Amino acid alignment of HOOK region of invertebrate and vertebrate LCavβ subunits. 
Conserved residues are highlighted and grouped by colour according to amino acid similarity. Note the 
conserved -PFFKK motif at the end of exon 7A, and the consistent size and location of exon 7B (although the 
sequence differs between invertebrates and vertebrates). Taken together these patterns of conservation suggest 
that exon 7A was likely present in the ancestral Cavβ subunit which evolved to form the invertebrate and 
vertebrate Cavβ subunits. Exon 7B was likely formed by a process of convergent evolution due to sequence 













Finally, in all four vertebrate Cavβ subunits, short isoforms are created when exon 7B 
(AKQKQKX) is included in place of exon7A or exon 7C.  Interestingly, splicing of exon 7 
was also observed in invertebrates, although exons 7A, 7B or 7C do not appear to be 
mutually exclusive, as they are in fish and mammals (figure 3.16). 
The HOOK region of molluscan and squid Cavβ subunits contain exons equivalent to 
7A and 7B (figure 3.16). Exon 7A (which ends in –PFFKK) was conserved in invertebrates, 
mammalian Cavβ1 and Cavβ2 and zebrafish Cavβ2.1, but appears to have been lost in 
mammalian and zebrafish Cavβ3 and Cavβ4 genes. Based on this observation, it is 
hypothesized that exon 7A was contained in a primordial Cavβ subunit from which all others 
have evolved. In mammalian Cavβ subunits, exons 7A and 7B of the HOOK region were 
mutually exclusive, unlike in invertebrates like Lymnaea and Loligo, where exon 7A was 
found to be constitutively expressed, while the short exon 7B was optional. Exon 7B was 
only present (upstream of exon 7A) in LCavβA+, LCavβB+ and LoCavβ1B isoforms, but not in 
LCavβB- or LoCavβ1A subunits. In LCavβA+ and LCavβB+, this exon (GVQFVSP) was identical 
in position and length but differed in amino acid composition from the vertebrate sequence of 
exon 7B; while in squid the optional exon (ECMFL) was in the same position but only five 
amino acids in length. The fact that the position, but not the sequence, of exon 7B is 
conserved points to the likelihood that the formation of these optional exons was driven by a 
process of convergent evolution after the divergence between molluscs, squid and 
vertebrates.  
During this process of convergent evolution, the HOOK domain insertions found in 
each species would have arisen independently by random mutation causing alterations to the 
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length of the HOOK domain. These changes in length were beneficial as they allowed for 
modulation of channel gating, and therefore were conserved in several species although they 
arose separately. Following this line of reasoning, it could be hypothesized that the ancestor 
of vertebrates evolved a separate, short isoform containing exon 7B (not found in 
invertebrates) that was found in all four Cavβ subunit genes (AKQKQKX), while 
invertebrates evolved entirely different mutations in the exact same region independently. 
This hypothesis explains why invertebrates have evolved an optional exon instead of 
mutually exclusive exon splicing as in vertebrates. This pattern of alternative splicing was 
interesting, because studies have implicated these regions in the modulation of channel 
biophysics in both squid (Kimura and Kubo, 2003) and mammals (Richards et al., 2007). 
How the presence of these inserts will affect the electrophysiology of LCavβ remains to be 
determined. 
3.5 Western Blotting of LCavβA+ and LCavβB+ 
 
Before analyzing how the trafficking and biophysics of LCav1 and LCav2 were influenced by 
LCavβ subunit expression, it was crucial to show that these proteins could be expressed 
heterologously in HEK 293T cells. In order to accomplish this task, Western blotting was 
carried out using lysate from HEK 293T cells transfected with LCavβA+, LCavβB+ or no DNA 
(mock transfection), as seen in figure 3.17. In lanes containing lysate from transfected cells, 
single bands of relatively similar intensity could be seen at approximately 60kDa. No bands 
were seen in the lane which contained lysate from the mock-transfected cells. This 




Figure 3.17: Western blot of LCavβ subunits. LCavβA+ and LCavβB+ were expressed in HEK 293T cells and 
lysed after five days of expression. LCavβA+ and LCavβB+ were detected by a rabbit anti- LCavβ antibody and a 
secondary antibody coupled to horseradish peroxidase. Cells that were transfected with LCavβA+ or LCavβB+ 
show expression of an appropriately sized protein (~60kDa), whereas mock-transfected cells do not, indicating 







62.63kDa, respectively. The lack of banding in the mock transfection sample indicated that 
there was no significant expression of endogenous Cavβ subunit that possesses epitopes 
similar to LCavβ in HEK 293T cells.  
 
3.6 Antibody Staining of LCavβ 
 
In order to visualize the cellular localization of LCav1, it was successfully cloned into a 
pEGFP-C1vector with an N-terminal fusion of EGFP in reading frame. A clone for the 
generation of EGFP-LCav2 was constructed previously in our laboratory in a similar fashion 
by Adriano Senatore. In order to confirm that the correct insert was present, restriction 
digestion was performed as seen in figure 3.18.  These digests verified that both LCav1 and 
LCav2 were present in their respective clones, and so these constructs were transfected into 
MSR cells in combination with various LCavβ subunit isoforms. These cells would be used in 
the fluorescent labeling of LCavβ subunits with antibodies, for the purpose of determining 
their subcellular distribution with respect to the α1 subunit.  
The results of staining MSR cells with a specific antibody generated against LCavβ 
subunit (which recognizes an epitope common to both LCavβA+ and LCavβB+) were rather 
inconclusive. Background staining remained high even under the most stringent conditions.  
Despite the high background, it was clear that some cells bore higher antibody staining 
(above background levels). This was in contrast to the untransfected control cells, where cells 
were all stained with equal intensity (figures 3.19 and 3.20). The images shown in figures 




Figure 3.18: Restriction digestion of LCav1-pEGFP-C1 and LCav2-pEGFP-C1. The identity of clones were 
confirmed by digestion with BamHI. Expected fragment sizes (LCav1-pEGFP-C1: 8.8kb, 1.8kb, 582bp; LCav2-
pEGFP-C1: 7.3kb, 2.8kb, 984bp) were produced, indicating that the clones are correct. Digested (C) and 










Antibody staining for LCav1 when co-expressed with LCavβA+ or LCavβB+ or in the 
absence of LCavβ, is depicted in figure 3.19. When LCavβ is not present, EGFP (linked to 
LCav1) is distributed diffusely throughout the cell, and only minimal red background is seen 
in all cells. For cells transfected with both LCavβA+ and LCavβB+, it was observed that LCav1 
was still fairly evenly distributed throughout the cell, although there appeared to be slightly 
more intense staining around, and near, the membrane. The distribution of both LCavβA+ and 
LCavβB+, were also concentrated nearer to the membrane, although there is still some 
cytoplasmic staining above background levels. Some cells in both instances, however, seem 
to be stained equally throughout the cell. Representative antibody staining for LCav2 is 
shown in figure 3.20 when co-transfected with LCavβA+, LCavβB+ or neither.  Some cells 
again seemed to contain equal distribution of LCavβ subunit (red) and LCav2 (green) 
fluorescence throughout the cell. This was true all the time in cells lacking LCavβ, but again, 
in cells which contained either LCavβA+ or LCavβB+, many cells were stained more heavily 
around the membrane. 
 It has been shown in mammals that Cavβ subunits assist in the membrane trafficking 
of the primary α1 subunit (Neuhuber et al., 1998; Raghib et al., 2001; Colecraft et al., 2002), 
but does the same effect occur for Lymnaea channels expressed in vitro? These results 
presented in figures 3.19 and 3.20 indicated that when LCavβ subunits were expressed with 
either LCav1 or LCav2, we see a rise in membrane insertion of the α1 subunit, and the LCavβ 
subunits seem to be colocalized, to some degree, with the α1 subunit. LCavβ subunits are 
expected to be found in the cytoplasm also because they are not membrane bound unless 




Figure 3.19: Localization of LCav1-EGFP and LCavβ in transfected  GripTite 293 MSR cells. 
Untransfected (UT) control cells are shown in the top row. LCav1 was directly tagged with EGFP (green), and 
LCavβ was labeled with anti- LCavβ antibody that was detected with an AlexaFlour594-conjugated secondary 










Figure 3.20: Localization of LCav2-EGFP and LCavβ in transfected  GripTite 293 MSR cells. 
Untransfected (UT) control cells are shown in the top row. LCav2 was directly tagged with EGFP (green), and 
LCavβ was labeled with anti- LCavβ antibody that was detected with an AlexaFlour594-conjugated secondary 









Table 3.1: Summary of LCav1 electrophysiology results. Data is given as mean±SEM. 
Electrophysiology LCavβA+ n LCavβB+ n LCavβB- n 
Gmax  (pS) 0.0515±0.0117 7 0.0824±0.0222 24 0.0386±0.0353 5 
Erev (mV) 55.19±1.45
§ 51.67±0.663# 50.35±2.63 
Activation V0.5(mV) 2.07±1.05
§ 0.475±0.0501#¶¶ 3.55±1.07§§ 
Ka 7.09±0.19 6.77±0.133 6.96±0.174 
Inactivation V0.5(mV) 
-12.84±4.56 2 -20.74±2.18 5 -18.10±0.723 3 
Ki 11.82±0.499
§ 8.42±0.578# 8.76±0.830 
Peak Current (pA) -111.01±17.99
¶ 7 -230.54±44.74 24 -178.28±11.69# 5 
Kinetics at 
-
10mV tpeak(ms) 61.24±9.50 66.12±9.08 18 64.72±9.06 
R350 0.284±0.0929
§ 0.479±0.036# 0.533±0.0530 
Kinetics at 0mV tpeak(ms) 64.86±12.22 51.31±5.56 65.64±11.20 
R350 0.557±0.0476
¶ 0.607±0.0179¶ 0.701±0.0251#§ 
Kinetics at 10mV tpeak(ms) 37.29±3.42 37.16±4.97 56.70±16.94 
R350 0.655±0.0428 0.608±0.0273
¶ 0.741±0.0522§ 
Kinetics at 20mV tpeak(ms) 38.66±5.24
§ 26.35±3.09#¶ 47.46±8.82§ 
R350 0.599±0.0424 0.549±0.0350 0.680±0.0777 
Kinetics at 30mV tpeak(ms) 24.94±5.63 23.32±2.38
¶ 37.70±8.44§ 
R350 0.465±0.0381 0.423±0.0459 0.571±0.102 
One Way ANOVA vs. LCavβA+:  #p<0.05, ##p<0.005 
One Way ANOVA vs. LCavβB+: §p<0.05, §§p<0.005 
One Way ANOVA vs. LCavβB-: ¶p<0.05, ¶¶p<0.005 
 
 
therefore should be strictly localized to the membrane. This suggested that the LCavβ 
subunits were complexing with the α1 subunit at the cell membrane, but their role in the 




The modulatory effects of the novel LCavβ subunits (LCavβB+ and LCavβB-) on snail LCav1 
and LCav2 channels expressed heterologously in HEK 293T cells were assessed using whole-
cell voltage clamping experiments. A summary of all electrophysiological data for LCav1and 
LCav2 is presented in tables 3.1 and 3.2, respectively. In an attempt to graphically summarize  
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Table 3.2: Summary of LCav2 electrophysiology results. Data is given as mean±SEM. 
Electrophysiology no LCavβ n LCavβA+ n LCavβB+ N LCavβB- n 


























#§¶¶ 6.74±0.27* 6.49±0.30* 6.13±0.30** 
Inactivation V0.5 











 10 -260.49±116.05 8 -289.09±46.85
**#
 7 






























































Tau act 0.89±0.12 0.96±0.21 0.82±0.10 1.00±0.27 5 
Tau 
inact 
40.58±7.61#¶¶ 67.92±9.74*§ 42.79±6.97#¶¶ 97.55±12.93**§§ 7 
One Way ANOVA vs. no LCavβ: *p<0.05, **p<0.005  
One Way ANOVA vs. LCavβA+:  #p<0.05, ##p<0.005 
One Way ANOVA vs. LCavβB+: §p<0.05, §§p<0.005 
One Way ANOVA vs. LCavβB-: ¶p<0.05, ¶¶p<0.005 
 
the modulatory effects of LCavβ subunits on calcium channel kinetics, representative traces 
of LCav1 and LCav2 (normalized to peak) can be seen in figures 3.21 and 3.22, respectively. 
It should be noted that there is no data for LCav1 in the absence of LCavβ subunits. Although 
more than 150 patches were made on cells from multiple transfections, no LCav1 currents 
were ever produced in the absence of LCavβ subunits. This suggests that the Cavβ subunit is 





Figure 3.21: Representative traces of LCav1. Traces were recorded in the presence of  LCavβA+, LCavβB+ or 
LCavβB- subunits at a test potential of 10mV for 450ms. Traces have been normalized to peak and then 














Figure 3.22: Representative traces of LCav2. Traces were recorded in the presence of  LCavβA+, LCavβB+ or 
LCavβB- subunits at a test potential of 30mV for 450ms. Traces have been normalized to peak and then 











electrophysiological properties imparted by differential LCavβ subunit expression and the 
physiological significance of these effects. 
 
3.7.1 Current-Voltage Relationships and Peak Current Amplitude 
 
Peak currents from LCav1 and LCav2 were measured from a holding potential of -100 mV to 
voltage steps in a range of -50 mV to +50 mV in 10mV increments.  These current-voltage 
relationships reflect the voltage-sensitivity of channels to opening in response to a 
depolarizing stimulus like an action potential.  Illustrated in figure 3.23, it is evident that 
neither LCavβA+, LCavβB+, nor LCavβB- significantly shifted the current-voltage curves of 
LCav1. The IV curves for LCav2 (figure 3.24) revealed only slight deviations in the current-
voltage relationship involving slight hyperpolarizing shifts induced by Cavβ subunit 
expression. A hyperpolarizing shift (to the left) indicates that there is a greater probability of 
channel opening at lower (more hyperpolarized) voltages.  In other words, more channels 
will be recruited to open in response to smaller depolarizations caused by the arrival of action 
potentials at the axon terminal. In effect, this would allow for the influx of Ca
2+
 into the cell 
to occur more rapidly since less stimulation would be required to activate channels. 
 Maximal peak currents from -50 mV to +50 mV were used to infer the effect of 
LCavβ subunit expression on the current density of LCav1 and LCav2. Since the maximal 
current size is dependent on the number of functional channels, it can be used to infer how 
many channels are being trafficked to the membrane. In mammalian systems, Cavβ subunits 




Figure 3.23: Current-Voltage relationship of LCav1. Comparison of LCav1 whole-cell current-voltage 
relationship when co-expressed with LCavβA+, LCavβB+ or LCavβB- subunits. No significant changes were noted. 










Figure 3.24: Current-Voltage relationship of LCav2. Comparison of LCav2 whole-cell current-voltage 
relationship when co-expressed with LCavβA+, LCavβB+ or LCavβB- or no LCavβ subunit. Curves have been fitted 








assisting in the assembly and membrane trafficking of the α1 subunit. The data from each 
current-voltage recording (regardless of the voltage) was used to construct the box plots of 
peak current amplitude for LCav1 and LCav2 in figures 3.25A and 3.26A, respectively. As 
both figures illustrate, there were some significant changes in the amplitude of the peak 
current for both LCav1 and LCav2 induced by the expression of Cavβ subunits. The co 
expression of LCavβA+ resulted in lower LCav1 current amplitude (-111.01±17.99 pA) when 
compared to either LCavβB- (-178.28±11.69 pA; p=0.018) or LCavβB+ (-230.54±44.74 pA; not 
statistically significant). In figure 3.26, it can be seen that LCavβB- caused an increase in the 
peak current of LCav2 (to -289.09±46.85 pA) as compared to no LCavβ subunit (-
56.93±13.94 pA; p=0.002) or LCavβA+ (-160.10±34.62 pA; p=0.039). Although the 
expression of LCav2 with LCavβB+ resulted in an average peak current of -260.49±116.05 pA, 
it did not result in any statistically significant differences due to the high level of variability 
between cells.     
The current through an ion channel is a function of the conductance and driving force.  
The driving force is a function of the membrane potential minus the reversal potential for that 
ion, and is greatest at low potentials when the difference between membrane and reversal 
potentials is greatest. However, at these low potentials, the calcium channels are not 
conducting or gating.  Whole-cell conductance is a function of the number of open channels, 
which increases with depolarization.  The amplitude of the currents in the IV curves were 
therefore influenced by both driving force and conductance, but when this data is 
transformed by the Boltzmann equation (as during the construction of activation curves) the 




Figure 3.25: Peak current amplitude and conductance of LCav1. (A) Box plots depicting peak current 
amplitude when LCav1 was co-expressed with either LCavβA+, LCavβB+ or LCavβB-. No currents were obtained 
in the absence of LCavβ  suggesting that LCavβ may be required for membrane expression of functional  LCav1 
channels. (B) Bar chart depicting the average  maximal conductance values when LCav1 was co-expressed with 
LCavβA+, LCavβB+ or LCavβB-. No changes in conductance were statistically significant (C) Scatter of individual 





Figure 3.26: Peak current amplitude and conductance of LCav2. (A) Box plots depicting peak current 
amplitude when LCav2 was co-expressed with either LCavβA+, LCavβB+ , LCavβB-  or no LCavβ subunit. 
Although peak current generally increased with LCavβ expression, only LCavβB- was significantly larger than no 
LCavβ and LCavβA+ (B) Bar chart depicting the average  maximal conductance values when LCav2 was co-
expressed with LCavβA+, LCavβB+ , LCavβB-  or no LCavβ. LCavβB+ expression resulted in lowered conductance 





constant, and so the whole-cell conductance values are therefore representative of the rate of 
ion flow into the cell through a single open channel multiplied by the number of recruited 
channels that are open. As figure 3.25 shows, there were no significant differences in 
maximal LCav1 conductance as a result of LCavβ subunit expression. The maximal 
conductance of LCav2 (0.0546±0.0148 pS), however, was lowered by LCavβ subunit 
expression (figure 3.26), although the only statistically significant decrease was caused by 
the expression of LCavβB+ (0.0288±0.00216 pS). In physiological terms, this decrease in 
conductance would lessen the amount of Ca
2+
 gated into the cell upon the arrival of an action 
potential, effectively dampening the release of neurotransmitters and other second-messenger 




3.7.2 Voltage-Dependence of Activation 
 
The current-voltage relationship data was subjected to a Boltzmann transformation and curve 
fit to produce the activation curves of LCav1 and LCav2.  These curves describe the fraction 
of channels that have opened (become activated) from the resting (closed) state upon 
depolarization to a given voltage. In studies of mammalian VGCCs expressed in HEK 293T 
cells, Cavβ subunits were found to generally cause a slight hyperpolarization of the voltage-
dependence of activation (Yasuda et al., 2004). Small, but statistically significant differences 
were seen in the half-activation potential (V0.5) of LCav1 (figure 3.27, table 3.1), which 
represents the potential at which 50% of the channels present in the cell have become 




Figure 3.27: Activation curve of LCav1.  Effect of LCavβ subunit isoforms on activation of LCav1 channels 
expressed in HEK 293T cells obtained by whole-cell patch clamp recording. Curves have been fitted with the 
Boltzmann equation and data points represent mean±SEM. Note that a small hyperpolarizing shift has been 








the half-activation potential to 0.475±0.0501mV as compared with 2.07±1.05mV (p=0.007) 
and 3.55±1.07mV (p=0.000) for LCavβA+ and LCavβB-, respectively. In physiological terms, 
this translates to more calcium entry into the cells at lower voltage thresholds, potentially 
leading to easier excitability of tissues expressing the LCavβB+ isoform. The hyperpolarizing 
shifts seen here are a hallmark feature of Cavβ subunit modulation and are also observed 
mammalian channels. 
Although no significant shifts in half-activation potential of the activation curve of 
LCav2 were noted, a hyperpolarizing effect was caused by a steepening of the slope of the 
activation curve (Ka), as illustrated in figure 3.28. The co-expression of any LCavβ isoform 
with LCav2 caused a significant decrease in Ka for all LCavβ subunit isoforms when 
compared to channels expressed in the absence of LCavβ subunits (LCavβA+: p=0.010; 
LCavβB+: p=0.006; LCavβB-: p=0.002). No significant differences in activation between the 
various LCavβ subunits were observed. Steepening of the curve indicates that the voltage-
sensing machinery has become more sensitive to voltage changes, such that the same 
depolarization causes greater conductance changes. These shifts in the voltage dependence of 
activation, in effect, increase the sensitivity of the calcium channel complex to a depolarizing 
stimulus such as an action potential. Under these conditions of increased voltage-sensitivity 
to depolarization, physiological process initiated by calcium influx, such as neurotransmitter 
release or muscle contraction, will occur more readily since less depolarization of the cell 






Figure 3.28: Activation curve of LCav2.  Effect of LCavβ subunit isoforms on activation of LCav2 channels 
expressed in HEK 293T cells obtained by whole-cell patch clamp recording. Curves have been  fitted with the 
Boltzmann equation and data points represent mean±SEM. Note that expression of LCavβA+, LCavβB+ and 








3.7.3 Steady-State Inactivation 
 
A steady-state inactivation curve measures the fraction of channels that have switched from 
the activated state to the inactivated (refractory) state at a given voltage. In order to assess the 
effect of LCavβ subunit expression on the steady state-inactivation of LCav1 and LCav2, a 
brief depolarizing step to peak (10mV for LCav1; 30mV for LCav2) was taken, followed by a 
long conditioning pulse in the voltage range of -100mV to 20mV (increasing by 10mV each 
sweep). This conditioning pulse lasted until channels were fully inactivated at peak potential 
(up to 15 seconds). After the long conditioning pulse, which induced inactivation in a subset 
of the population of channels, a second brief step to peak was taken to assess the fraction of 
channels that are inactivated by sustained depolarization to a given potential.  
Steady-state inactivation analysis of LCav1 (figure 3.29) revealed no significant shifts 
in the half-inactivation potentials, although the standard error values were quite large (Table 
3.1). The half-inactivation potential is the voltage at which 50% of channels in a given 
population have reverted from the open state to an inactivated, refractory state and cannot be 
opened regardless of the depolarizing stimulus. When the slope of the inactivation curve (Ki) 
was compared there was a significant difference (p=0.019) noted between LCavβA+ 
(11.82±0.499) and LCavβB+ (8.42±0.578). Although the Ki of LCavβB- was 8.76±0.830, it was 
not statistically different from LCavβA+ (p=0.122). These changes in Ki indicate that when 
LCavβA+ was expressed, the steady-state inactivation of LCav1 was altered in such a way that 
the inactivation of channels was less sensitive to increases in membrane potential, allowing 
channels to remain open longer thereby increasing Ca
2+





Figure 3.29: Steady-state inactivation curves of LCav1. Effect of LCavβ subunit isoforms on steady-state 
inactivation of LCav1 channels expressed in HEK 293T cells. Data was obtained by whole-cell patch clamp 
recording and curves have been  fitted with the Boltzmann equation . Data points represent mean±SEM. Co-







Analysis of the effect of LCavβ subunit expression on the steady-state inactivation of 
LCav2 has produced some interesting results, as seen in figure 3.30. Most notably, the slope 
of the inactivation curve is drastically steepened when LCavβB- is co-expressed with LCav2, 
in comparison to no LCavβ subunit (p=0.004), LCavβA+ (p=0.042) or LCavβB+ (p=0.011). 
This signifies that the steady-state inactivation of LCav2 was delayed in the presence of 
LCavβB-, and then occurred more rapidly as compared to other LCavβ subunit isoforms 
indicating an increase in the voltage-sensitivity of inactivation. When the half-inactivation 
potentials were compared, some differences were noted (Table 3.1). However, the only 
statistically significant difference was the shift from -25.23±1.32mV to -33.12±4.20mV 
(p=0.049) when we compare the co-expression of LCav2 with LCavβA+ and LCavβB+, 
respectively. Although similar differences were observed in other datasets, they were not 
statistically significant, and so it appears as though the expression of LCavβA+ caused 
channels to delay entry into the refractory state until greater levels of depolarization are 
reached. The effects induced by the expression of LCavβA+ would allow LCav2 channels to 
remain open longer thereby increasing total Ca
2+
 influx into the cell. Ordinarily, sustained 
influx of Ca
2+
 is halted by channel inactivation.  The refractory state of the channels keeps 
the levels of free Ca
2+
 in the cytosol from elevating to toxic levels. Physiologically, a longer 
duration of Ca
2+
 influx will allow for downstream processes affected by Ca
2+
, such as muscle 







Figure 3.30: Steady-state inactivation curves of LCav2. Effect of LCavβ subunit isoforms on steady-state 
inactivation of LCav2 channels expressed in HEK 293T cells. Data was obtained by whole-cell patch clamp 
recording and curves have been  fitted with the Boltzmann equation . Data points represent mean±SEM. Co-
expression of LCavβA+ produced a depolarizing shift due to an increase in the half-inactivation potential, while 






3.7.4 Gating Kinetics 
 
Finally, it was important to examine the kinetics of activation and inactivation. Activation 
kinetics describe the speed with which a population of channels open after receiving a 
depolarizing stimulus and can be measured several ways. The activation kinetics of LCav1 
were measured as the time to reach peak (in ms) after the application of a depolarizing 
stimulus, while the tau values of activation were calculated for LCav2. Tau values represent 
the point in time when two thirds of channels present in a cell have opened. In both cases, 
larger values indicate an increased latency period between depolarization and activation due 
to conformational changes which must occur in the α1 subunit. Activation was found to be 
voltage dependent, so values were measured at test pulses of different voltages.  In mammals, 
the expression of Cavβ subunits was found to speed up activation kinetics in some cases.  
When the effects of LCavβ subunit expression on activation kinetics of LCav1 were 
compared, few significant differences were noted as illustrated in figure 3.31. The expression 
of the LCavβB- subunit resulted in an increase in the time to peak current, as compared to 
LCavβB+, when cells were depolarized to 20mV and 30mV. At 20mV, the time to peak 
current increased from 26.35±3.09ms in the presence of LCavβB+ to 47.46±8.82ms when 
LCavβB- was expressed (p=0.009). Similarly, at 30mV, the time to peak had increased 
(p=0.031) from 23.32±2.38ms (when LCavβB+was expressed) to 37.70±8.44ms when exon 
7B was removed (as in LCavβB-). The time to activation was also considerably slower in the 
presence of LCavβA+ (38.66±5.24ms) as compared to LCavβB+ (p=0.049),but not LCavβB-. It 
is evident by comparison of LCavβB+ and LCavβB- that the seven amino acid insert in the 




Figure 3.31: Activation kinetics of  LCav1. Effects of LCavβ expression on the time to peak (ms) is plotted as a 
measure of  latency to channel opening. Bars represent mean±SEM. When the kinetics imparted by LCavβB+ and 
LCavβB- were compared, it was observed that the presence of exon 7B (in LCavβB+) mediated an increase in the 







rapid activation means that there will be increased Ca
2+
 influx as channels are able to open 
quicker, leading to more rapid coupling of electrical and chemical signals such as the arrival 
of an action potential at a nerve terminal and neurotransmitter exocytosis or muscle 
contraction.  
The kinetics of LCav2 activation were not significantly altered by the coexpression of 
LCavβ subunits. The only exception is that the tau of activation at 10mV (figure 3.32) was 
slightly raised and lowered, respectively, when LCavβA+or LCavβB+ were expressed. As 
compared to a tau of activation of 1.66±0.24ms in the absence of LCavβ subunits, it 
increased to 1.75±0.17ms with LCavβA+ (p=0.049) and decreased to 1.25±0.17ms with 
LCavβB+ (p=0.040). Perhaps the reciprocal effects of LCavβA+ and LCavβB+ are 
physiologically relevant as they could act in concert to effectively fine-tune electrochemical 
coupling mechanisms, however, this is unclear as the expression of LCavβB- had no effect on 
the tau of activation. 
Similar to activation kinetics, inactivation kinetics can be quantified several ways. 
Due to the extremely slow inactivation of LCav1, the rate of inactivation was measured by 
determining the fraction of current that remained 350ms after reaching peak (R350). Since the 
inactivation of LCav2 was more rapid, the inactivation decay could be fit with an exponential 
curve that allowed for the determination of the tau of inactivation, which is a parameter that 
represents the time after peak when approximately two thirds of all channels in a cell have 
entered the inactivated state. In either case, the larger the R350 or tau, the slower the 
inactivation kinetics (channels are delaying the transition from the open state to the refractory 




Figure 3.32: Activation kinetics of  LCav2. Effects of LCavβ expression on the tau of activation are plotted  as 
a measure of latency to channel opening. Bars represent mean±SEM.  No significant difference in activation of 








test pulses of different voltages. In mammals, Cavβ subunit expression has varying effects on 
the kinetics of inactivation, with Cavβ2a slowing it while the other three Cavβ subunits either 
accelerate it or have no effect (Yasuda et al., 2004). 
The inactivation kinetics of LCav1 seemed to be affected by LCavβ subunit 
expression, especially in the range of -10 to 10mV. The R350 plot seen in figure 3.33 shows 
that when LCav1 is expressed with LCavβB-, the inactivation is slowed as compared to 
LCavβA+ or LCavβB+. These differences were significant when cells were depolarized to 0mV, 
as compared to LCavβA+ (p=0.039) and LCavβB+ (p=0.018), whereas at 10mV it is only 
different from LCavβB+ (p=0.034). One interesting finding is that, at -10mV, the R350 is 
increased by the expression of LCavβB+ or LCavβB- (as compared to LCavβA+), although the 
only statistically significant difference was with LCavβB+ (p=0.025). Based on these 
observations it appears as though the removal of exon 7B from the HOOK region has 
resulted in delayed inactivation of LCav1, which would allow for sustained calcium influx 
into the cell over long periods of depolarization.     
At voltage ranges around and slightly above peak, there were several interesting 
changes in the tau of inactivation for LCav2 induced by the differential expression of LCavβ 
subunits (figure 3.34). Interestingly, the tau of inactivation is always highest when LCav2 is 
coexpressed with LCavβB-. At voltages of 20mV, 30mV and 40 mV, these differences are 
statistically significant as compared to cells not expressing LCavβ (p=0.003, 0.000, 0.001) 
and LCavβB+ (p=0.030, 0.005, 0.005). LCavβA+ was only significantly different at 30mV 
(p=0.026) with a tau of inactivation that was higher than that of no LCavβ and LCavβB+. This 




Figure 3.33: Inactivation kinetics of LCav1. R350 values are plotted as a representation of the ability of 
LCavβA+, LCavβB+ and LCavβB-  to modulate the the speed with which whole-cell inactivation decay occurs. 
Bars represent mean±SEM. In the voltage range around peak (0 and 10mV), co-expression of LCavβB- appears 










Figure 3.34: Inactivation kinetics of LCav2. Tau values for the fast component of inactivation are plotted as a 
representation of the ability of LCavβA+, LCavβB+ and LCavβB-  to modulate the speed with which whole-cell 
inactivation decay occurs. Bars represent mean±SEM. Inactivation of LCav2 was severely attenuated by the co-








LCav2 channels, similar to the phenomenon that was observed for LCav1. It was also noted 
that, at the same voltage range, expression of LCavβA+ also caused a slowing of inactivation 
as compared to no LCavβ and LCavβB+. It seems as though the LCavβ subunit isoforms slow 
inactivation kinetics to some extent, and that the HOOK region may be instrumental in the 
modulation of inactivation properties. Delaying the inactivation of the calcium channels can 
have several physiologically relevant effects, due to the overall increase in Ca
2+
 influx that 
results. Increased Ca
2+
 influx will lead to an increase in activities like muscle contractility or 

















It has been the goal of this project to address the manner in which Cavβ subunits 
differentially regulate the expression and activity of HVA calcium channels in Lymnaea 
stagnalis. Several interesting findings have been presented in this study which help to 
elucidate the role of LCavβ subunits in the modulation of LCav1 and LCav2 expression and 
biophysics. First, it has been shown that alternative splicing of the LCavβ subunit does occur 
in the N-terminus and HOOK regions and that this is acommon feature of all Cavβ subunits. 
Next, it has been shown that the invertebrate LCavβ subunits can be expressed heterologously 
in mammalian cell culture, and that co-expression of LCavβ subunits with LCav1 or LCav2 
can produce physiological effects in vitro. Co-expression of LCavβ subunits has enhanced the 
membrane trafficking of functional α1 subunits and modulated their biophysical properties. 
Taken together, this work has broadened our understanding of the physiology of voltage-
gated calcium channels in the simple model organism Lymnaea, in an attempt to further our 
understanding of the function of Cavβ subunits.  
 
4.1 Alternative Splicing of the N-terminus and HOOK Region Is a 
Common Feature of Cavβ Subunits 
 
It had often been theorized that alternative splicing played a large role in the Cavβ subunit 
modulation of invertebrate calcium channels since they contain only a single homolog of the 
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four genes that encode Cavβ subunits in mammals (Spafford et al., 2004). Studies have 
shown that while the core MAGUK-like structure of the Cavβ subunit SH3 and GK domains 
remained highly conserved among all Cavβ subunits, the HOOK region and N-terminus can 
be highly variable (figure 3.1) and are often subjected to alternative splicing (Vendel et al., 
2006; Chen et al., 2004; Foell et al., 2004; Helton and Horne, 2002; Hanlon et al., 1999). As 
it has been shown here, there were multiple splice isoforms present in LCavβ- two of which 
were cloned and characterized in this study. Screening of Lymnaea cDNA revealed the 
presence of LCavβB+ and LCavβB-, in which a mutually exclusive N-terminus has replaced 
that found in LCavβA+. This finding was significant since it had been previously shown that 
alternative splicing of the N-terminus could be found in invertebrate Cavβ subunits (Kimura 
and Kubo, 2003; Moroz et al., 2006) as well as mammalian Cavβ2 and Cavβ4 subunits 
(Colecraft et al., 2002; Helton and Horne, 2002; Takahashi et al., 2003; Foell et al., 2004; 
Vendel et al., 2006).  
 These alternate splice isoforms were found to have differential expression patterns 
and the ability to modulate the biophysical properties of both Cav1 and Cav2 channels. For 
instance, Helton and Horne (2002) were able to demonstrate that alternative splicing in the 
A-domain of the N-terminus of Cavβ4 produced two mutually exclusive isoforms- Cavβ4a and 
Cavβ4b, whose N-termini are substantially different in length. The length of the N-terminus in 
Cavβ4a was 49 amino acid residues, whereas that of Cavβ4b was a mere 15 amino acids in 
length as seen tables 4.1 and 4.2 (found at the end of this chapter). From an 
electrophysiological perspective, it was shown that Cavβ4a and Cavβ4b have differential 
effects on the voltage-dependencies of activation and inactivation, as well as the inactivation 
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kinetics of Cav2.2 channels, but not Cav1.2 (Helton and Horne, 2002). In addition to this 
finding, it was also found that the expression patterns of Cavβ4a and Cavβ4b in the cerebellum 
were non-overlaping.  It was observed that Cavβ4a and Cavβ4b were localized to different 
layers and subcellular locations in the cerebellum- Cavβ4a  was preferentially expressed at 
synapses in the molecular layer, while Cavβ4b is expressed in the Purkinje cell bodies and 
other cells that cross the molecular layer (Vendel et al., 2006). Furthermore, it has been 
shown that each of the five N-terminal splice variants of Cavβ2 impart different gating 
properties to Cav1.2 channels when expressed in HEK cells (Takahashi et al., 2003). Some 
isoforms of Cavβ2 (Cavβ2a and Cavβ2e) contain palmitoylation sites in the N-terminus (Chien 
et al., 1996), while others (Cavβ2b, Cavβ2c and Cavβ2d) do not. Palmitoylation of the N-
terminus allowed the Cavβ subunit to become anchored in the cell membrane and drastically 
alter the peak ionic current (Chien et al., 1996) and induce slower inactivation kinetics 
(Takahashi et al., 2003).  Based on these previous findings, it was not surprising that 
alternative splicing was also present in the N-terminal A-domain of LCavβ.  
 Serendipitously, alternative splicing was also discovered in the HOOK region of 
LCavβ. Exon 7 of LCavβA+ and LCavβB+ was found to contain an optional seven amino acid 
insert (exon 7B; GVQFVSP), which was not present in LCavβB- (see figures 3.6 and 3.16). 
Alternative splicing has also been noted in the HOOK region (exon 7) in both squid (Loligo) 
Cavβ subunits (Kimura and Kubo, 2003) and mammalian Cavβ1 (Powers et al., 1992) and 
Cavβ2 (Takahashi et al., 2003) subunits, as well as zebrafish Cavβ2 (Zhou et al., 2008). In 
squid, exon 7B consists of a five amino acid insert (ECMFL) that is optional and may or may 
not be expressed with the long exon 7A; however, in mammals and fish exons 7A and 7B are 
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mutually exclusive, leading to “long” and “short” isoforms which encode either exon 7A or 
7B, respectively (figure 3.16). Alternative splicing of the HOOK region was a promising 
target for investigation as it has been directly implicated in the modulation of inactivation 
kinetics of calcium channels (Richards et al., 2007).  
When Cavβ1b and Cavβ2a were mutated such that the entire HOOK region had been 
deleted, Richards et al. (2007) found that the inactivation kinetics of Cav2.2 currents were 
enhanced, resulting in faster whole-cell inactivation decay. The N-terminus, SH3 and GK 
domains were found not to be involved in this alteration of inactivation kinetics through the 
use of strategically truncated mutant controls (Richards et al., 2007). In Lymnaea, it is likely 
that alternative splicing may be responsible for channel type-specific regulation since they do 
not have the genetic diversity seen in mammals, but rather contain only a single homolog of 
the four mammalian Cavβ subunit genes. In the field of neuroscience, characterization of the 
functional and structural significance of alternative splicing events, such as these, remains a 
challenge. 
 
4.2 Genomic Structure of Lymnaea Cavβ Subunit is Conserved in 
Vertebrates 
 
In order to ensure that there was in fact only a single gene coding for LCavβ, Southern 
blotting analysis was carried out with limited success. Previous studies had indicated the 
presence of only a single gene as multiple rounds of PCR screening (Spafford et al., 2004) 
did not reveal additional LCavβ subunit genes. Using LCavβB N-terminus as a probe, it 
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appears as only a single copy in a Southern  blot hybridrization experiment (figure 3.11B). It 
remains unclear, however, if LCavβA is truly a single-copy gene as Southern blotting failed to 
produce definitive proof (figure 3.11A). Although several attempts were made to 
troubleshoot the Southern blotting of LCavβA, in each attempt the result was the same- two 
faint bands were produced in each lane. This could be caused by two possible situations: 
either the gene is not a single-copy gene, or there is an intron present which divides the 
sequence epitope that is recognized by the DIG-labeled probe. Of these two possibilities, the 
latter is more likely based on the previous findings of other groups (Spafford et al., 2004) and 
the fact that both bands visualized on the blot of LCavβA were of roughly equal intensity, yet 
not as intense as those on the blot for LCavβB. Since the bands were of approximately equal 
intensity, it could be argued that an intron may be present because the DIG signal was 
divided between the two fragments of DNA. Since the percent GC composition and size of 
the DIG-labeled probes for both LCavβA and LCavβB was comparable, it would also have 
been expected that both probes would hybridize equally well, producing bands of comparable 
intensity given that all other factors were the same. Finally, when the blots of LCavβA and 
LCavβB are compared, it was evident that the position of one of the bands produced by 
LCavβA correlated roughly with the band seen in the blot of LCavβB. This had suggested, 
again, that both probes were binding to the same fragment (containing the single-copy gene), 
yet LCavβA was also binding to another fragment which perhaps was on the other side of a 
restriction site (which divided the LCavβA hybridization site in two). For these reasons, it was 
inferred that Lymnaea contains only a singleton homolog of the Cavβ subunit. 
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 In an attempt to confirm that both LCavβA and LCavβB are alternative splice isoforms 
of a single LCavβ gene, genomic sequencing of the N-terminus was subsequently carried out. 
Introns separating exon B and C, and C and D were found to be 516 and 2263bp in length, 
respectively, and were bounded by consensus donor and acceptor sites to facilitate 
spliceosome activity (figure 3.14 B and C). Similar genomic structure is conserved in the N-
terminus of mammalian (figure 3.14A) and teleost Cavβ2 and Cavβ4 genes (Birnbaumer et al., 
1998; Foell et al., 2004; Vendel et al., 2006, Ebert et al., 2008a; Ebert et al., 2008b). As 
illustrated in figure 3.14A, alternative splicing in the N-terminus of Cavβ2 and Cavβ4 is 
common, and results in at least two mutually exclusive N-terminal domains which 
themselves were products of either two exons or a single exon. Based on these findings and 
the results of Southern blotting (figure 3.11), it can be concluded that the splicing pattern 
observed in mammalian Cavβ2 and Cavβ4 genes is conserved in Lymnaea, such that the N-
terminus of LCavβA (MALA….FIRQ) is coded for by two exons upstream of a single B exon 
that encodes the N-terminus of LCavβB (MRIK….IDSL). This consistent pattern of 
conservation suggests that invertebrate and vertebrate Cavβ subunits have arisen from a 
common ancestral protein.  
 Several studies have noted that the N-terminus of Cavβ subunit genes contain some of 
the longest known introns in both humans and fish. In humans, these introns can range from 
90 to 125kb in length in Cavβ2 and Cavβ4 (Ebert et al., 2008a,b), although the average human 
intron size is only 3.7kb and less than one-quarter of introns in the human genome are greater 
than 2.6kb (Sakharkar et al., 2004; Hong et al., 2006). Likewise, the N-terminal introns of 
teleost fish (zebrafish and pufferfish) are also significantly larger than average, ranking them 
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among the largest of all fish introns (Ebert et al., 2008a,b; Aparicio et al., 2002). Several 
other tetrapod Cavβ subunits were also found to contain disproportionately large introns in 
the N-terminus of their Cavβ subunits (Ebert et al., 2008a,b). Could the conservation of these 
large introns be due to the presence of important regulatory elements that control isoform 
expression and alternative-splicing of the N-terminus? Cis-regulatory elements contained 
within non-coding (intron) sequence have been shown to influence mRNA metabolism and 
processing in several fundamental ways, including modulation of transcription rate (by 
controlling accessibility to DNA and polyadenylation), nuclear export, translation and 
degradation of mRNA transcripts (Le Hir et al., 2003; Nott et al., 2003). Therefore, 
conservation of large intron size in the N-terminus may be due to the presence of important 
cis-regulatory elements found within them. These elements may take part in the modulation 
of isoform expression at both the transcriptional and translational levels, allowing an 
organism to spatially and temporally regulate Cavβ subunit expression.     
 It has been shown that the HOOK region of the Cavβ subunits of invertebrates, 
mammals and fish are alternatively spliced in similar manners (see section 4.1), although it 
seems as though splicing patterns suggest that divergence of invertebrate and vertebrate Cavβ 
subunit isoforms in the HOOK domain occurred after the split between these two groups 
occurred millions of years ago. The HOOK domain of Cavβ consists of exons 6 and 7, and 
exon 7 can be divided into exons 7A, 7B and 7C which may expressed in different 
configuration (figure 3.16). All organisms included in this study were found to contain exon 
6, which was moderately conserved among species (figure 3.1), however the patterns of 
splicing in exon 7 were not consistent between invertebrates and vertebrates. The 
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invertebrates Lymnaea and Loligo contained exon 7A, and sometimes contained an optional, 
short exon just upstream (exon 7B). Vertebrates, however, contained either exon 7A or 7B, 
but not both (i.e. they were mutually exclusive). Also, the amino acid composition of exon 
7B differed drastically between Lymnaea, squid and vertebrates, although the size of exon 7B 
was always short (seven amino acids in Lymnaea and vertebrates, five in squid; figure 3.16). 
Given these facts, it is likely that sequence divergence within the HOOK region did not occur 
in an ancestral Cavβ subunit, but rather after the split between molluscs, squid and 
vertebrates. The commonalities found in the loci and size and putative functions of exon 7B 
has lead to the hypothesis that these exons may have been the result of convergent evolution 
since the sequence of theis exon differs between molluscs, squid and vertebrates. In the 
process of convergent evolution, the independent formation of exon 7B in molluscs, squid 
and mammals was driven by the ability of random mutations in the HOOK region to impart 
new modulatory effects on HVA VGCCs. These modulatory effects, in turn, would have 
been beneficial as it would allow for fine-tuning of channel gating activity, and so these 
independently-evolved isoforms of exon 7B remain today in the genomes of molluscs, squid, 
fish and mammals. 
 
4.3 Lymnaea Cavβ Subunits Enhance Peak Current Amplitude and Assist 
in Membrane Trafficking of LCav1 and LCav2 
 
It was previously known that HEK cells could express LCavβA+ (Spafford et al., 2004), but 
would it express LCavβB+ as well, if at all?  Prior to assessing the role of LCavβA+, LCavβB+ 
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and LCavβB- in the membrane trafficking of LCav1 and LCav2, Western blotting was used to 
validate the expression of LCavβ proteins in cultured HEK cells (figure 3.17). It was 
determined that both LCavβA+ and LCavβB+ are expressed in HEK cells that have been 
transfected with these plasmids, however, in mock transfected cells no proteins were detected 
by the rabbit anti-LCavβ antibody. This indicates that there is, in fact, transcription, 
translation and expression of the LCavβ proteins in HEK cells that have been transfected, and 
that no endogenous HEK cell proteins are recognized by the anti-LCavβ antibody. The lack of 
endogenous Cavβ subunit expression is important as it ensures that any modulation of 
channel biophysics is indeed caused by the LCavβ subunit isoform in question. Therefore, it 
was suitable to have used cultured, transfected HEK cells for fluorescent imaging and 
electrophysiological analysis of LCavβ induced modulation of LCav1 and LCav2. 
 It has been previously reported that co-expression of mammalian Cavβ subunits with 
mammalian HVA calcium channels resulted in a drastic increase in the whole-cell peak 
current amplitude when expressed in cell culture. It has been postulated by several groups 
that the observed enhancement of peak current amplitude was due to a “chaperoning” role of 
Cavβ subunits in the membrane trafficking of the primary α1 subunit to the membrane (Chien 
et al., 1995; Yamaguchi et al., 1998; Gao et al., 1999; Brice et al., 1997). In order to rule out 
changes in the level of α1 expression as the cause of current enhancement, immunolabelling 
experiments were employed. With both Cav1 and Cav2 channels, the α1 subunit exhibited 
perinuclear staining of the cytoplasm in the absence of LCavβ subunit expression. Likewise, 
when expressed in the absence of other VGCC subunits, Cavβ subunits (except the 
palmitoylated Cavβ2a) were diffusely localized to the cytoplasm. In all cases, the co-
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expression of Cav1 or Cav2 with any Cavβ subunit led to an increase in the membrane 
localization of the α1 and Cavβ subunits, which appeared to cluster together (Chien et al., 
1995; Yamaguchi et al., 1998; Gao et al., 1999; Brice et al., 1997). As further evidence that 
Cavβ subunits may act as a “chaperone” in the trafficking of α1 subunits to the membrane, it 
was observed that when Xenopus oocytes were pre-treated (prior to expression of calcium 
channels) with vacuolar-type H
+
-ATPase (V-ATPase) inhibitor, which impairs intracellular 
transportation by acidifying vacuoles, both the enhancement of peak current amplitude and 
localization of α1 to the membrane were abolished (Yamaguchi et al., 1998). This evidence 
clearly implicates Cavβ subunits in the intracellular transport of calcium channel α1 subunits 
to the cell surface, but is this the case for invertebrates like Lymnaea? 
As illustrated in figure 3.26, the average peak current of LCav2 was enhanced when 
the α1 subunit was co-expressed with any of the three LCavβ isoforms, although the increases 
were only statistically significant for LCavβB-, due to large variability and low repeat values 
in the other datasets (leading to a large standard error). Co-expression of LCavβB-, also 
resulted in an average peak current for LCav2 that was larger than that for LCavβA+ (figure 
3.26). As for LCav1, it was difficult to determine if LCavβ subunit expression enhanced 
membrane trafficking (and therefore peak current amplitude) because no LCav1 currents were 
recorded in the absence of LCavβ subunits. Could it be that perhaps there were no currents 
recorded because LCav1 was not being inserted into the membrane in the absence of an 
LCavβ subunit chaperone? The fact that currents in excess of 100pA were consistently 
produced when LCav1 was co-expressed with LCavβA+, LCavβB+ or LCavβB- (figure 3.25) 
lends credibility to this hypothesis. To further investigate the role of LCavβ subunits in 
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membrane trafficking, fluorescent labeling of α1 and LCavβ subunits expressed in HEK 293T 
cells was preformed. 
Although the anti-LCavβ antibody showed a high degree of specificity in Western blot 
analysis, there was some degree of background staining present when fluorescent antibody 
staining experiments were carried out. HEK 293T cells were transfected with either LCav1 or 
LCav2 channels that have been fused to EGFP at the N-terminus and LCavβ subunits were 
localized by means of an LCavβ subunit-specific antibody that can be detected with a 
secondary antibody conjugated to AlexaFluor594.  As seen in the upper row of figures 3.19 
and 3.20, untransfected cells were consistently stained at low levels when imaged for EGFP 
(green) and AlexaFlour594 (red). When transfected cells were imaged with the fluorescent 
microscope, it was evident that some cells were more intensely stained than others. Cells 
with fluorescence above background levels indicated positively transfected cells because the 
higher levels of fluorescence are a result of EGFP-fused channel (green) expression or LCavβ 
(red) expression detected by fluorescent (secondary) antibodies in these cells. Thus it was 
possible to distinguish true signal from background fluorescence. 
Among cells transfected with either LCav1 or LCav2, some differences related to 
LCavβ subunit expression became evident. In the absence of any LCavβ, both EGFP-LCav1 
and -LCav2 were always distributed diffusely throughout the cell, as seen in the second row 
of figure 3.19 and 3.20, respectively. This is comparable to what has been observed for 
mammalian Cav1 and Cav2 channels in the absence of Cavβ subunit expression (Chien et al., 
1995; Yamaguchi et al., 1998; Gao et al., 1999; Brice et al., 1997), and so it appears that in 
the absence of LCavβ expression both LCav1 and LCav2 fail to insert in the cell membrane. 
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Membrane trafficking of both LCav1 and LCav2 appeared to have been restored by the 
expression of either LCavβA+ or LCavβB+ (LCavβB- was not tested). As seen in the bottom two 
lines of figures 3.19 and 3.20, the majority of cells showed at least a partial co-localization of 
LCav1 and LCav2, respectively, with either LCavβ isoform at the cell membrane. In many of 
these instances, however, there remained a significant amount of EGFP-LCav1 or –LCav2 in 
the cytoplasm and it was often difficult to determine if channels were significantly localized 
in the membrane. On the other hand, the LCavβ subunit staining with AlexaFlour594 clearly 
revealed higher levels of membrane localization when transfected with LCav1 or LCav2. 
Again, this is consistent with previous reports that have noted co-localization of mammalian 
α1 and Cavβ subunits when they are co-expressed (Chien et al., 1995; Yamaguchi et al., 
1998; Gao et al., 1999; Brice et al., 1997), except for the diffuse perinuclear staining of α1 
which remained in the cytoplasm.  Earlier studies that have also shown that LCav2 and 
LCavβA+ do indeed co-localize at the cell membrane when co-expressed in HEK cells 
(Spafford et al., 2004). The fact that there is no difference between LCavβA+ and LCavβB+ 
was not surprising, given the fact that the hydrophobic groove found in the GK domain has 
been implicated as the major determinant of trafficking of α1 (Chen et al., 2004; Bichet et al., 
2000), and the GK domains of LCavβA+ and LCavβB+ are identical. Although there were no 
apparent differences in membrane trafficking of LCav1 or LCav2 due to changes in LCavβ 
expression, differences in whole-cell peak current of both channels were induced by 





4.4 Lymnaea Cavβ Subunits Subtly Modulate the Voltage-Dependencies 
of Activation and Inactivation 
 
It has long been reported that Cavβ subunits can regulate the biophysical properties of HVA 
calcium channels, including their voltage-dependencies of activation and inactivation. Not 
surprisingly, this was true of LCavβ subunits as well, although the modulatory effects seem to 
be quite subtle. Although it is well-established that mammalian Cavβ subunits modulate 
channel gating, the degree to which these parameters are altered, however, may depend on 
the expression system used. Some studies have found enhanced Cavβ subunit modulation of 
channel gating when Xenopus oocytes are used for heterologous expression of channel 
complexes as compared to mammalian systems such as HEK 293T or COS-7 cells (Yasusda 
et al., 2004). In order to minimize the quantitative differences resulting from artifacts of the 
expression system, only qualitative differences will be highlighted when possible. Tables 4.1 
and 4.2 summarize the qualitative effects of Cavβ subunit modulation on L-type and non-L-
type HVA calcium channels, respectively, from several invertebrate and vertebrate species. 
All of the LCavβ subunit isoforms, expressed here in HEK cells, appeared to have 
clear, but subtle effects on the voltage-dependencies of activation and inactivation of LCav2. 
As illustrated in figure 3.28, a hyperpolarizing shift in the voltage-dependency of activation 
was caused by the co-expression of LCavβA+, LCavβB+ or LCavβB-, due to a steepening of the 
slope of the activation curve (Ka). The half-activation potentials of LCav2, although not 
statistically significant, differed by five to ten millivolts depending on which LCavβ isoform 
was expressed. This is consistent with what has been reported previously when mammalian 
Cavβ subunits have been expressed in HEK 293T cells. Representatives of all four 
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mammalian Cavβ subunits, Cavβ1b, Cavβ2a, Cavβ3, Cavβ4a and Cavβ4b, have been reported to 
decrease (steepen) the slope of the activation curve of LCav2 (Helton and Horne, 2003; 
Yasuda et al., 2004). The alteration of the slope usually resulted in a hyperpolarizing shift 
that was less than 5mV in magnitude (except in the case of Cavβ4a, in which no shift 
resulted). Previous reports have suggested that LCavβA+ had no effect on the voltage-
dependence of activation for LCav2, contradictory to what was observed here (Spafford et al., 
2004). Perhaps the hyperpolarization of the activation curve is caused by specific 
determinants located in the N-terminus of the α1 subunit, as the aforementioned study utilized 
a chimeric LCav2 channel which contained the N-terminus from rat Cav2.1.  
Physiologically, hyperpolarizing shifts in the voltage-dependence of activation results 
in a population of channels which have increased sensitivity to depolarizing stimuli. By 
modulating the expression of Cavβ subunits in a given cell or at a particular synapse, an 
organism can fine-tune their physiological response to a given stimulus. For example, in 
some instances an organism may want to strengthen the coupling between a neuronal signal 
and its physical response, as in the arrival of an action potential and muscle contraction seen 
in excitation-contraction coupling. One mechanism by which this coupling could occur more 
rapidly is to allow the entry of Ca
2+
 into the cell with less depolarization (leading to the 
observed hyperpolarizing shift). Hyperpolarizing the voltage-dependence of activation 
effectively lowers the threshold of depolarization that is required for activation.  
Modulation of steady-state inactivation has been a hallmark of Cavβ subunit 
expression, and it appears that this holds true for Lymnaea subunits to some extent. It was 
evident from figure 3.30 that the N-terminus and HOOK region were having an influence on 
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the steady-state inactivation of LCav2. In the absence of exon 7B (GVQFVSP), the slope of 
the inactivation curve (Ki) was drastically decreased (table 3.2) compared to all other 
datasets, indicating that steady-state inactivation was delayed until cells were exposed to 
more depolarized membrane potentials. Under these conditions, the transition of LCav2 
channels from open (activated) to inactivated would be delayed until the membrane was 
depolarized to a greater extent. Upon reaching the threshold for inactivation, however, the 
population of channels would achieve inactivation more rapidly because there were no 
alterations to the half-inactivation potential induced by LCavβB- expression.  
Aside from the HOOK region, it also appeared that the N-terminus may alter the 
steady-state inactivation properties of LCav2. Small, depolarizing shifts in the half-
inactivation potential of LCav2 were observed when co-expressed with LCavβA+, as seen in 
figure 3.30, and ranged from 4 to 8mV in magnitude, although these shifts were only 
significant when compared to LCavβB+ (table 3.2). In mammalian systems, steady-state 
inactivation of Cav2 channels can be shifted in either a hyperpolarizing or depolarizing 
direction depending on which Cavβ subunit gene or isoform is expressed (table 4.2). In 
general, mammalian Cavβ1b, Cavβ3 and Cavβ4b were reported to induce small hyperpolarizing 
shifts in the half-inactivation potential of Cav2 without alteration of the slope of the 
inactivation curve, Ki (except for Cavβ1b which resulted in a slight decrease in the slope) 
(Yasuda et al., 2004). On the other hand, it is well-documented that Cavβ2a expression results 
in a large depolarization of the steady-state inactivation curve due to palmitoylation of its N-
terminus, and does not allow for full inactivation of all channels within a given population 
(Yasuda et al., 2004). Cavβ4a was found to have no effect on the steady-state inactivation of 
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Cav2. Interestingly, both squid Cavβ subunits (LoCavBeta1a and LoCavBeta1b) were also 
found to depolarize the steady-state inactivation curves of Cav2 channels, and similar to 
Cavβ2a, they also did not allow for full inactivation of all channels in a given population 
although they do not contain palmitoylation motifs in their N-termini (Kimura and Kubo, 
2003). 
Depolarization of the steady-state inactivation curve of LCav2 by expression of 
LCavβA+ could potentially have meaningful physiological ramifications. Depolarizing shifts 
in the steady-state inactivation curve indicates that within a given population of channels, any 
one channel is more likely to be open at a given potential. For example, a right shift of the 
steady-state inactivation curve extends the range of depolarization a channel is able to 
tolerate prior to reverting to a refractory state allowing for increased calcium influx into the 
cytoplasm. In a sense, shifts of this nature act to “desensitize” a population of channels to 
inhibition by repeated stimuli (such as a train of action potentials) which maintain higher-
than-normal levels of depolarization. In the absence of Cavβ subunits which depolarize the 
voltage-dependence of inactivation, channels would more readily become refractory to 
opening, effectively limiting the duration of the downstream physiological response 
(including neurotransmitter secretion and muscle contraction).  
The lack of LCav1 recording data in the absence of Cavβ subunits did not allow for a 
direct comparison of LCavβ subunit modulation, since there was no basis for comparison. 
Despite this fact, some differences in the voltage-dependencies of activation and inactivation 
were noted between LCav1 channel complexes containing different LCavβ subunit isoforms. 
It was noted that the half-activation potential of LCav1 was hyperpolarized by the expression 
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of LCavβB+, as compared to either LCavβA+ or LCavβB-. Although the shift was statistically 
significant, it is unlikely to be of physiological significance since the magnitude of the shift 
was less than 3mV (figure 3.27 and table 3.1). As for the steady-state inactivation of LCav1, 
it was noted that the expression of LCavβA+ increased the average half-inactivation potential 
of LCav1 by 6 to 8mV. Although these differences were not statistically significant, there was 
a significant increase in the slope of the inactivation curve (Ki) of LCav1 when it was co-
expressed with LCavβA+ as compared to either LCavβB isoform. This decrease in the steepness 
of the curve has created the appearance of a hyperpolarizing shift although the changes in 
half-inactivation differences were not statistically significant. As with LCav2, depolarization 
of the voltage-dependence of inactivation will allow for greater calcium influx over extended 
periods of depolarization, in effect “desensitizing” the population of channels to inhibition by 
a prolonged stimulus.    
In the absence of a no Cavβ subunit control, it has been exceedingly difficult to try 
and elucidate the modulatory effects of LCavβ subunits on LCav1 as it has often been 
observed that mammalian L-type (Cav1) channels are often modulated by Cavβ subunits in an 
isoform-specific manner. For example, in mammalian systems Cavβ1a, Cavβ2a, Cavβ3 and 
Cavβ4b all shift the half-activation potentials in a hyperpolarizing direction, but yet Cavβ1b, 
Cavβ2b and Cavβ4a do not induce any shifts. In addition, the slope of the activation curve was 
decreased when LCav1 was co-expressed with Cavβ1b, Cavβ4a and Cavβ4b, but not in the 
presence of other Cavβ subunits (Jangsangthong et al., 2009; Yasuda et al., 2004; Takahashi 
et al., 2003; Helton and Horne, 2002).  Similarly, when the Cavβ subunit modulation of the 
steady-state inactivation of Cav1.2 was studied, it was found that mammalian Cavβ1a, Cavβ1b, 
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Cavβ3 and Cavβ4b induced hyperpolarizing shifts in the half-inactivation potential ranging 
from 5 to 12mV in magnitude while Cavβ2a induced a 7mV depolarizing shift, and Cavβ2b and 
Cavβ4a had no effect (Jangsangthong et al., 2009; Yasuda et al., 2004, Helton and Horne, 
2002). Since mammalian Cavβ subunits do not modulate L-type calcium channels in 
predictable and consistent ways, it has not been possible to attribute differences observed in 
the voltage-dependencies of activation and inactivation of LCav1 to specific LCavβ subunit 
isoforms.  
 
4.5 The N-terminus and HOOK Regions of the Cavβ Subunit Modulate 
Channel Kinetics 
 
Perhaps the most characteristic feature of Cavβ subunits is their ability to mediate calcium 
channel kinetics. VGCCs can exist in three functional states- open, closed or inactivated- and 
the speed with which channels transition between these states can be modulated by Cavβ 
subunits in mammals (Jones, 1998). Likewise, invertebrate Cavβ subunits appear to modulate 
the kinetics of both LCav1 and LCav2, and evidence suggests that both the N-terminus and 
HOOK regions contain important determinants of this effect.  
The HOOK region is involved in modulating the kinetics of LCav2 inactivation as 
seen in figure 3.34. When the exon 7B (GVQFVSP) was removed from the HOOK region, 
the tau of inactivation increased (table 3.2), which indicated a delay in channel inactivation. 
The role of the HOOK region is evident when we compare LCavβB+ and LCavβB-, since they 
only differed by the seven amino acids encoded by exon 7B. LCavβA+ also increased the tau 
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of inactivation as compared to the absence of LCavβ subunit and LCavβB+ (although the latter 
differences were not statistically significant at all tested potentials, see table 3.2). This is 
comparable to previous research that had reported slowed inactivation kinetics when LCav2 
was co-expressed with LCavβA+ (Spafford et al., 2004). Therefore, it seems that both the N-
terminus and HOOK region act to modulate inactivation kinetics of LCav2, with both exons 
A1 and A2 as well as exon 7B (GVQFVSP) slowing inactivation. Similar trends were 
observed in the modulation of Cav2.3 channels by squid Cavβ subunits, LoCavBeta1a and 
LoCavBeta1b, which both caused a slowing of inactivation kinetics (Kimura and Kubo, 2003). 
Mammalian Cavβ subunits are known to both enhance and inhibit the inactivation kinetics of 
Cav2.2 (table 4.2). Inactivation was significantly sped up by Cavβ3, and to a lesser extent by 
Cavβ1b, whereas Cavβ2a slowed inactivation drastically (Yasuda et al., 2004). Cavβ4b had no 
effect on inactivation kinetics of Cav2.2, while Cavβ4a induced an increase in rate of 
inactivation kinetics (Helton and Horne, 2002; Yasuda et al., 2004). Due to the numerous 
differences between individual Cavβ subunit isoforms it has been difficult to pinpoint the 
exact structural determinants of the observed modulatory effects. 
Figure 3.34 clearly illustrates that the removal of exon 7B (GVQFVSP) from the 
HOOK region of LCavβB resulted in slower inactivation kinetics of LCav2. Published reports 
investigating mammalian Cavβ subunits have suggested the opposite effect is occurring. 
Mutagenesis studies had found that the removal of the entire HOOK region from human 
Cavβ1b and Cavβ2a subunits resulted in more rapid inactivation kinetics of human Cav2.2 
channels expressed in vitro (Richards et al., 2007). In squid, both LoCavBeta1a and 
LoCavBeta1b mediated slowing of Cav2.3 inactivation, although inactivation was delayed to a 
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greater extent by LoCavBeta1b, which contains exon 7B (Kimura and Kubo, 2003). It seems 
that exon 7B of invertebrate Cavβ subunits may be responsible, at least in part, for the slower 
inactivation kinetics observed for Cav2 channels. In vertebrates, exon 7A (long) and 7B 
(short) are mutually exclusive to each other and appear to have opposing effects on Cav2 
inactivation kinetics (table 4.2). Isoforms containing the long exon 7A mediate slowed 
inactivation kinetics, whereas those expressing the shorter exon 7B tend to modulate more 
rapid inactivation of Cav2 channels. Perhaps then, it is not the actual structure of the HOOK 
region that is important in modulating inactivation kinetics, but rather its length and the 
positioning of exon 7B that are important. This hypothesis is supported by the fact that the 
exact position of exon 7B has been conserved across vertebrate and invertebrate species, 
although the sequence has not. There does not appear to be any correlation between the 
length or structure of the Cavβ subunit N-terminus and its observed effects on Cav2 channel 
kinetics (table 4.2).   
When the kinetics of LCav1 (expressed with the three LCavβ isoforms) were 
compared, it was determined that the GVQFVSP insert in the HOOK region (exon 7B) was 
also influential in the modulation of L-type calcium channels. The removal of exon 7B 
resulted in slower activation (figure 3.31) and inactivation (figure 3.33), although the 
differences were not always statistically significant (Table 3.1). The observed differences 
between LCavβB- and the other LCavβ subunit isoforms were found to increase as the 
membrane potential was increased. This suggested that the removal of exon 7B in the HOOK 
region is responsible for slowing the kinetics of activation and inactivation of LCav1. No 
differences in LCav1 kinetics were consistently observed between LCavβA+ and LCavβB+, 
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which differ only in the structure of the N-terminus, indicating that this region has no effect 
on LCav1 kinetics.  
Cavβ subunit modulation of mammalian Cav1.2 channel kinetics is highly dependent 
on the specific isoform that is expressed. Most mammalian Cavβ subunits did not alter Cav1.2 
kinetics, however Cavβ1a and Cavβ2b were found to enhance inactivation (table 4.2), resulting 
in more rapidly inactivating whole-cell currents, while Cavβ2a had the opposite effect 
(Jangsangthong et al., 2009; Yasuda et al., 2004; Takahashi et al., 2003; Helton and Horne, 
2002). Only Cavβ2b was observed to mediate activation kinetics, resulting in a slight decrease 
in the latency to channel opening (Takahashi et al., 2003). Some groups have reported that 
the length of the N-terminus, and not necessarily its structure, is critical in determining the 
kinetics of Cav1.2 activation and inactivation (Herzig et al., 2007; Jangsangthong et al., 
2009). For both Cavβ1 and Cavβ2, shorter N-terminal domains produced Cav1.2 currents 
which inactivated more rapidly. Is it possible then that the same could be true of the LCavβ 
subunit? If this were true, then it is consistent with the hypothesis that no differences in 
LCav1 kinetics were observed between LCavβA+ and LCavβB+, since their N-terminal domains 
differ by only two amino acid residues in length (table 4.1 and 4.2). Investigation of N-




In conclusion, it has been shown that alternative splice isoforms of the Lymnaea Cavβ subunit 
are present, and that they can modulate HVA calcium channels in vitro. Two novel isoforms, 
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LCavβB+ and LCavβB-, have been sequenced and cloned, both of which contain an alternative 
N-terminus.In addition, LCavβB+ contains a small, optional insert in the HOOK region (exon 
7B). Staining with fluorescent antibodies and analysis of whole-cell peak currents has 
revealed that both LCavβA+ and LCavβB+ were able to enhance membrane trafficking of 
Lymnaea calcium channels to some degree. Finally, it was shown that these novel LCavβ 
isoforms, as well as LCavβA+, have the ability to modulate the biophysical properties of both 
LCav1 and LCav2 in a manner that is similar to Cavβ subunit modulation of mammalian HVA 
calcium channels. Understanding the effects of Cavβ subunit modulation of calcium channel 
function in the simplified invertebrate system of Lymnaea will contribute to our 
understanding of our own highly complex nervous systems. 
 
4.7 Future Considerations 
 
The findings of this project have shed light on some areas for future investigation which will 
help to clarify the roles of alternatively-spliced Cavβ subunits in HVA calcium channel 
modulation. In many of the datasets the standard error was quite large, often leading to 
statistical anomalies which need to be resolved. This could easily be accomplished by 
increasing the number of repeats (n-values) in each dataset in the hopes of decreasing the 
standard error (and the standard deviation used in the ANOVA). Increasing the n-values, and 
thereby hopefully decreasing the standard error, may reveal statistically significant 
differences that, at present, are not considered significant presenting a clearer picture of the 
true nature of LCavβ subunit modulation of invertebrate HVA calcium channels.  
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In order to truly understand the LCavβ subunit modulation of LCav1 it would be 
critical to have recordings in the absence of Cavβ subunits, but this has not been possible to 
date (see section 4.2). Comparison of the biophysical properties of LCav1 and rat Cav1.2 
channels has shown that these channels are nearly identical in their voltage-dependency on 
activation and inactivation as well as their gating kinetics (Senatore et al., unpublished data), 
and so it would be useful to include rat Cav1.2 as a reference with which to compare the 
modulatory effects of LCavβ subunits. By increasing the number of experimental repeats and 
including a Cav1.2 comparison, it should be possible to gain further insight into the 
modulation of HVA calcium channels by LCavβ subunit splice isoforms. 
 In order to identify the patterns of LCavβ subunit expression, it would be helpful to 
perform quantitative real-time PCR on RNA extracted from various Lymnaea tissues (both 
neural and otherwise) at several developmental stages (eggs, juveniles and adults). 
Quantitative real-time PCR would identify where and when various LCavβ subunit isoforms 
were expressed and to what extent they are present relative to other alternatively spliced 
isoforms. This information could provide clues as to the function of each LCavβ isoform and 
the type of physiological or developmental effects it mediates. Along these same lines, the 
development of isoform-specific antibodies would allow for the determination of specific 
expression patterns in the Lymnaea central ring ganglia using fluorescently labeled secondary 
antibodies.  
These antibodies could also be used for co-immunoprecipitation experiments to 
determine if there are any differences in the protein-protein interactions between alternatively 
spliced LCavβ isoforms. It has been suggested that the largest role of the N-terminus of Cavβ 
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subunits likely involves secondary protein interactions which act to fine-tune HVA calcium 
channel activity (Maltez et al., 2005). Therefore, determining what, if any, differences are 
present in protein binding ability would help to fully evaluate the function of each LCavβ 
isoform, thereby enhancing our understanding of VGCC physiology. 
Much work still needs to be completed in order to fully understand the roles of 
specific structural motifs found in Cavβ subunits, and how they affect channel 
electrophysiology. In order to tease apart the roles of the N-terminus and exon 7B in the 
modulation of channel gating and kinetics, a mutant LCavβA- subunit could be created that 
would contain exons A1 and A2 in the N-terminus but lack exon 7B (GVQFVSP) in the 
HOOK region. By creating and expressing LCavβA-, it would be possible to determine with 
some degree of certainty which domains are responsible for the observed modulatory effects 
on LCav1 and LCav2.  Also, creation of LCavβ subunit mutants which have been truncated at 
various methionine residues in the N-terminus may assist in determining if its length is 
indeed a factor affecting LCav1 modulation as was observed for mammalian Cav1.2 channels 
(Jangsangthong et al., 2009; Herzig et al., 2007). Finally, sequencing of the N-terminus of 
the LCavβ subunit should also be completed to confirm the genomic structure upstream of 
exon B. New primers targeting a combination of intron and exon sequence can be created and 
used in a similar fashion those described in the genomic sequencing of exons B, C and D and 
the introns between them. 
The goal of this project was to enhance our understanding of how Cavβ subunits can 
modulate the expression and biophysical properties of VGCCs. Completion of further 
experimental repeats, quantitative real-time PCR and genomic sequencing, as well as the 
 
 145 
inclusion of mammalian Cav1.2 for biophysical comparison and creation of isoform-specific 
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